SlideShare a Scribd company logo
1 of 48
1
Get Homework/Assignment Done
Homeworkping.com
Homework Help
https://www.homeworkping.com/
Research Paper help
https://www.homeworkping.com/
Online Tutoring
https://www.homeworkping.com/
click here for freelancing tutoring sites
INTRODUCTION
Myocardial (heart muscle) dysfunction occurs very commonly, usually due to other
diseases such as coronary artery disease, high blood pressure, and diseases of the heart valves.
Disease originating in the heart muscle itself (cardiomyopathy) is much rarer.
Unfortunately, by the time it is diagnosed, the disease often has reached an advanced
stage andheart failure has occurred. Consequently, about 50 percent of patients with dilated
cardiomyopathy live 5 years once heart failure is diagnosed; about 25 percent live 10 years after
such a diagnosis. Typically, patients die from a continued decline in heart muscle strength, but
some die suddenly of irregular heartbeats.
2
For patients with advanced disease, heart transplantation greatly improves survival: 75
percent of patients live 5 years after a transplantation. However, the disease also may remain
fairly stable for years, especially with treatment and regular evaluation by a physician.
Cardiomyopathy is a result of pre-existing medical condition and can lead to a more
serious heart disease. There are 79, 320 cases of death cause cardiomyopathy in the whole
world. The following Table1.1 is showing the mortality rate based from (WHO) World Health
Organization Statistics Information Systems compiled January, 2004 .
WORLDWIDE MORBILITY CASES OF DILATED CARDIOMYOPATHY
The following Table 1.2 attempts to show morbidity extrapolate prevalence rate for
Dilated cardiomyopathy to the populations of various countries and regions. These prevalence
extrapolations for Dilated cardiomyopathy are only estimates, based on applying the prevalence
rates from the US (or a similar country) to the population of other countries, and therefore may
have very limited relevance to the actual prevalence of Dilated cardiomyopathy in any region:
Country/Region Extrapolated Prevalence Population Estimated Used
Dilated cardiomyopathy in North America (Extrapolated Statistics)
USA 587,310 293,655,4051
Canada 65,015 32,507,8742
Table 1.1 Mortality Statistics
3
Mexico 209,919 104,959,5942
Dilated cardiomyopathy in Central America (Extrapolated Statistics)
Belize 545 272,9452
Guatemala 28,561 14,280,5962
Nicaragua 10,719 5,359,7592
Dilated cardiomyopathy in Caribbean (Extrapolated Statistics)
Puerto Rico 7,795 3,897,9602
Dilated cardiomyopathy in South America (Extrapolated Statistics)
Brazil 368,202 184,101,1092
Chile 31,647 15,823,9572
Colombia 84,621 42,310,7752
Paraguay 12,382 6,191,3682
Peru 55,088 27,544,3052
Venezuela 50,034 25,017,3872
Dilated cardiomyopathy in Northern Europe (Extrapolated Statistics)
Denmark 10,826 5,413,3922
Finland 10,429 5,214,5122
Iceland 587 293,9662
Sweden 17,972 8,986,4002
Dilated cardiomyopathy in Western Europe (Extrapolated Statistics)
Britain (United Kingdom) 120,541 60,270,708 for UK2
Belgium 20,696 10,348,2762
France 120,848 60,424,2132
Ireland 7,939 3,969,5582
Luxembourg 925 462,6902
Monaco 64 32,2702
Netherlands (Holland) 32,636 16,318,1992
United Kingdom 120,541 60,270,7082
Wales 5,836 2,918,0002
Dilated cardiomyopathy in Central Europe (Extrapolated Statistics)
Austria 16,349 8,174,7622
Czech Republic 2,492 1,0246,1782
Germany 164,849 82,424,6092
Hungary 20,064 10,032,3752
Liechtenstein 66 33,4362
Poland 77,252 38,626,3492
Slovakia 10,847 5,423,5672
Slovenia 4,022 2,011,473 2
Switzerland 14,901 7,450,8672
4
Dilated cardiomyopathy in Eastern Europe (Extrapolated Statistics)
Belarus 20,621 10,310,5202
Estonia 2,683 1,341,6642
Latvia 4,612 2,306,3062
Lithuania 7,215 3,607,8992
Russia 287,948 143,974,0592
Ukraine 95,464 47,732,0792
Dilated cardiomyopathy in the Southwestern Europe (Extrapolated Statistics)
Azerbaijan 15,736 7,868,3852
Georgia 9,387 4,693,8922
Portugal 21,048 10,524,1452
Spain 80,561 40,280,7802
Dilated cardiomyopathy in Southern Europe (Extrapolated Statistics)
Greece 21,295 10,647,5292
Italy 116,114 58,057,4772
Dilated cardiomyopathy in the Southeastern Europe (Extrapolated Statistics)
Albania 7,089 3,544,8082
Bosnia and Herzegovina 815 407,6082
Bulgaria 15,035 7,517,9732
Croatia 8,993 4,496,8692
Macedonia 4,080 2,040,0852
Romania 44,711 22,355,5512
Serbia and Montenegro 21,651 10,825,9002
Dilated cardiomyopathy in Northern Asia (Extrapolated Statistics)
Mongolia 5,502 2,751,3142
Dilated cardiomyopathy in Central Asia (Extrapolated Statistics)
Kazakhstan 30,287 15,143,7042
Tajikistan 14,023 7,011,556 2
Uzbekistan 52,820 26,410,4162
Dilated cardiomyopathy in Eastern Asia (Extrapolated Statistics)
China 2,597,695 1,298,847,6242
Hong Kong s.a.r. 13,710 6,855,1252
Japan 254,666 127,333,0022
Macau s.a.r. 890 445,2862
North Korea 45,395 22,697,5532
South Korea 96,467 48,233,7602
Taiwan 45,499 22,749,8382
Dilated cardiomyopathy in Southwestern Asia (Extrapolated Statistics)
Turkey 137,787 68,893,9182
5
Dilated cardiomyopathy in Southern Asia (Extrapolated Statistics)
Afghanistan 57,027 28,513,6772
Bangladesh 282,680 141,340,4762
Bhutan 4,371 2,185,5692
India 2,130,141 1,065,070,6072
Pakistan 318,392 159,196,3362
Sri Lanka 39,810 19,905,1652
Dilated cardiomyopathy in Southeastern Asia (Extrapolated Statistics)
East Timor 2,038 1,019,2522
Indonesia 476,905 238,452,9522
Laos 12,136 6,068,1172
Malaysia 47,044 23,522,4822
Philippines 172,483 86,241,6972
Singapore 8,707 4,353,8932
Thailand 129,731 64,865,5232
Vietnam 165,325 82,662,8002
Dilated cardiomyopathy in the Middle East (Extrapolated Statistics)
Gaza strip 2,649 1,324,9912
Iran 135,006 67,503,2052
Iraq 50,749 25,374,6912
Israel 12,398 6,199,0082
Jordan 11,222 5,611,2022
Kuwait 4,515 2,257,5492
Lebanon 7,554 3,777,2182
Saudi Arabia 51,591 25,795,9382
Syria 36,033 18,016,8742
United Arab Emirates 5,047 2,523,9152
West Bank 4,622 2,311,2042
Yemen 40,049 20,024,8672
Dilated cardiomyopathy in Northern Africa (Extrapolated Statistics)
Egypt 152,234 76,117,4212
Libya 11,263 5,631,5852
Sudan 78,296 39,148,1622
Dilated cardiomyopathy in Western Africa (Extrapolated Statistics)
Congo Brazzaville 5,996 2,998,0402
Ghana 41,514 20,757,0322
Liberia 6,781 3,390,6352
Niger 22,721 11,360,5382
Nigeria 35,500 12,5750,3562
6
Senegal 21,704 10,852,1472
Sierra leone 11,767 5,883,8892
Dilated cardiomyopathy in Central Africa (Extrapolated Statistics)
Central African Republic 7,484 3,742,4822
Chad 19,077 9,538,5442
Congo Kinshasa 116,634 58,317,0302
Rwanda 16,477 8,238,6732
Dilated cardiomyopathy in Eastern Africa (Extrapolated Statistics)
Ethiopia 142,673 71,336,5712
Kenya 65,964 32,982,1092
Somalia 16,609 8,304,6012
Tanzania 72,141 36,070,7992
Uganda 52,780 26,390,2582
Dilated cardiomyopathy in Southern Africa (Extrapolated Statistics)
Angola 21,957 10,978,5522
Botswana 3,278 1,639,2312
South Africa 88,896 44,448,4702
Swaziland 2,338 1,169,2412
Zambia 22,051 11,025,6902
Zimbabwe 7,343 1,2671,8602
Dilated cardiomyopathy in Oceania (Extrapolated Statistics)
Australia 39,826 19,913,1442
New Zealand 7,987 3,993,8172
Papua New Guinea 10,840 5,420,2802
Table 1.2 Morbidity Extrapolate Prevalence rate for Dilated Cardiomyopathy
Source:
US Census Bureau, Population Estimates, 2004
US Census Bureau, International Data Base, 2004
LOCAL MORBIDITY STATISTICS
In this Table 1.3 shows the morbidity rate in the Philippines on 2000- 2004 & 2005. The
disease of the heart was 7th most leading cause of morbidity cases ranges 43, 898. And highest
most leading cause is Acute Lower Respiratory Infection ranging 690,566.
7
Table 1.3 Morbidit:10 Leading Causes, Number and Rate.
OBJECTIVES OF THE STUDY
General Objectives
Readers will be able to gain more knowledge and information about cardiomyopathy. As
third year students, we learned patient based heart complication. In this matter, what we learned
inside the room will be able to apply to an actual patient depending on the condition his needs.
Patient centered
- Gather all necessary data of the patient that are related to heart disease that are available
as is may be helpful to case study.
- Present the definition of the complete diagnosis that will explain the illness or
complication.
- Study the anatomy and physiology of that certain body part that is affected by the
complication.
- Trace the pathophysiology of cardiac disease (cardiomyopathy).
- Determined the possible diagnostic test needed for the case including implication and
nursing responsibility for the needs of the patient.
8
- Formulate a nursing care base plan on the possible secondary complication.
- Evaluate complications to nursing practice, education and research.
- To render health teachings and guidelines to those patients in the future for them to
prevent the risk of heart failure.
- The student nurse wants to learn actual complication that may occur on the future.
Nurse centered
After the completion of the case study the student nurse should be able to:
- Present comprehensive and detailed report regarding the complication.
- Have a well-structured nursing diagnosis of the complication based on patient integration
data.
- Understand the factors that might have been contributed to the development of the
complication.
- To provide an organized and structured nursing interventions as a response to the patient
anticipated needs.
- Provide relevant information on available alternative therapies and management.
NURSING ASSESSMENT
FAMILY GENOGRAM
Mr. Ferding (code name) not his real name is the youngest siblings from Mr.
Swirding(father of client, 65, deceased ) and Mrs. Sorayna(mother of client, 72, deceased). Five
of the family membersare alive and well. Three of his brother and two sisters died with a history
of cardiac arrest and 2 died in spontaneous abortion.
His grandparents on mother side and father side, most of them died in cardiac arrest as he
stated when we did an interview with him. See Figure 1.1 to elaborate more on his family tree.
9
Figure 1.1FAMILY TREE
(FAMILY HEALTH/ ILLNESS HISTORY)
PERSONAL HISTORY
Mr. Ferding (code name) not his real name is a 53 yrs. old male born on April 30 1959.
His parents are both gone, he has siblings 7 of them are already gone while 6 are still alive. He
married his wife (Esme) at the age of 25 yrs. old. Now he is a father of 6 children.
Mr. Ferding and his family are protestant. He is a carpenter and is earning enough to
support his family including their education.
Lifestyle and Activities of Daily Living
Family Lifestyle
Mr. Ferding works 6 days a week fixing and repairing houses while his wife takes care of
their children at home. Their children are quite good and they are cooperative when they are told
to do so.
Activities of Daily Living
Mr. Ferding usually gets up at 5 am to prepare himself to go for work. He will just eat at
6 AM, at 7 AM he will now go to his work. During morning until 12 at noon then have his lunch
for 1 hr. After 1 hr. he will now start working again for another 5 hrs. When he comes home at 5
pm he will just take a short break. He will then make sure that all his children is home at 7-8
10
before they eat their dinner. At 9 pm Mr. Ferding usually on bed ready to sleep and prepare for
the next day routine.
Eating Pattern
Mr. Ferding stated that he likes to eat heavy meals because of the kind of his work. He
eats fried rice in the morning to sustain his activities. He also eats rice and partner usually with
meat or fish and vegetables at noon and dinner. His wife is the one who prepares his food for
work.
Bowel and Bladder Elimination
Mr. Ferding stated that he is usually defecates once a day. Sometimes he exerts effort just
to expel it. But when he feels like he is constipated, he drinks warm liquid after a while he will
then go to the toilet. He also stated that he have no hard time urinating, there is no pain or any
burning sensation.
Family Relationship
Mr. Ferding stated that he is a family man. He always makes sure that all his children is
equally given attention to. He also added that his children are open to share their problems. And
as a father he always gives advice with an open minded.
Home and Neighborhood Condition
Ms. Ferdings house is consisting of 3 bedrooms, 1 for him and his wife, 1 for his girls
and the other is for his boys. The bedroom of his children is consisting of bunk beds. They have
living room and kitchen. They have friendly neighbors and never had been in the fight before.
HISTORY OF PAST AND PRESENT ILLNESS
Past Illness
According to Mr. Ferding20 years ago he was a smoker then, and was diagnosed with
hypertension. He did not comply with maintenance medication because he cannot afford it
and he feel like he still have hypertension after a while so he thought he was ok and no need to
take it.
Present Illness
11
Mr. Ferding decided to go to the hospital because of excessive coughing and feeling of
easy fatigability.
June 22- 2 weeks prior to admission Mr. Ferding experiences slight chills and fever but he still
went to work. When he came home he took Biogesic for his fever and since his daughter is a
nurse he just ask her to take his vital signs. Everything was normal but a slightly elevated
temperature. The next morning he felt ok. Then decided to go back to work
July 6 -1 day prior to admission experienced coughing and feeling of easy fatigability. He did
not got to work and he took a rest hoping that it will go away.
July 7 - 1 hour prior to admission Mr. Ferdingexperiencedexcessive coughing and DOB.
ACTUAL PHYSICAL ASSESSMENT
Nutrition assessment
The muscle tone of the patient was firm and developed with unequal strength on the
upper peripheral extremities. Body fat was equally distributed in the waist thighs and triceps.
Posture was erect but difficulty walking. The patient experienced easy fatigability. Skin is
rough, dry and decrease skin turgor. Nail was firm and pale nail beds. Hair was brittle and
dry. Lips are puffy with visible fissures on the corner of the mouth. Eyes are clear and pale.
There was normal reflex. Apical rate of 73 bpm and a blood pressure of 110/70.
Skin and nail assessment
Brown color skin, there was a thick but smooth texture with a clammy temperature.
Skin turgor of 5 seconds. There was a presence of grade 2 edema in the lower extremities.
Patient had a black dry hair. Scalp was symmetrical smooth and there was no presence of lesion
and no parasites. There was a round nail with 180 O nail base, thick in texture and immobile.
Head and Neck
Head was symmetrical round hard and smooth. Face was symmetrical centered head
position. Neck had a smooth and control movement and ROM of (flexion-45O , extension-55 O ,
12
lateral abduction-40 O , and rotation-70 O .) trachea and thyroid are in the midline position and
non-tender.
Eyes and Ears
Blinking was symmetrical and involuntary. Cornea was transparent, iris and pupils are
round and equal. Iris was clear and uniform in color. There was no discharge and tenderness on
the lacrimal apparatus upon palpation. Pinna of the ear was aligned with corner of the eye. Skin
smooth without nodule and color was the same with the face. Auricle tragus was non-tender
upon palpation. Mastoid process was not-tender when palpated, warm in temperature and easily
palpated without edema.
Mouth throat and nose
Lips and surrounding tissues are relatively symmetrical in position. There was fissure
and puffiness on the side of the mouth when smiling. Tongue was fissure and moves smoothly
and slightly pale in color. Color of the nose was the same as the face, smooth and symmetrical
in appearance. There was visible nasal flaring during inspiration. There are no nodules, masses
or pain reported during palpation. Sinuses are non-tender during palpation.
Chest and Lungs
Color in the chest was slightly pallor, intercostals space is retracting during with RR of
24 bpm. Chest symmetrical was equal. There was no pain upon palpation but there was a
presence of wheezing sound on both lung fields.
Heart
Apical pulse was 73 bpm upon auscultation with 53 PR upon palpation.
Peripheral vascular
Brachial artery blood pressure of 110/70 mmhg, 53 bpm PR. Extremities are slightly
pallor. Temperature of 34.2 O can identify pain. Radial pulse was weak and slow. Lower
extremities are slightly pallor with grade 2 bipedal edema. Verbalized no calf pain.
13
ANATOMY AND PHYSIOLOGY
Figure 1.2 Layers of the heart
Pericardial cavity–the space between the layers of the pericardium contains
approximately 10 – 30 ml of fluid. Parietal pericardium-surround almost the entire ascending
aorta and main pulmonary artery as well as portion of the inferior and superior vena cava and
the pulmonary vein. Fibrous pericardium ( Parietal Layer) surrounds the heart and attaches to the
great vessels which are several large blood vessels that return blood to the heart. Coronary blood
vessel the blood vessels that supplies oxygen and nutrient to the heart itself. Endocardium is the
inner layer of the heart where the blood is filled during cardiac relaxation. Myocardium is
responsible for contraction and expelling blood during cardiac contraction. Epicardium( Visceral
Pericardium ) contains the epicardial coronary arteries and veins. This is the inner lining of the
pericardium; it is delicate inner lining of the parietal pericardium and is the outer lining the great
vessel. (See figure 1.2)
14
Figure1.3Bloodflowillustration
Blood Flow
First, superior vena cava carries deoxygenated blood from the upper extremities while
inferior vena cava carries .deoxygenated blood from lower extremities. From the vena cava’s
blood will drain in the right atrium. From the right atrium blood will now go to the right ventricle
through the tricuspid valve. From right ventricle deoxygenated blood will pass through the
pulmonary valve and pulmonary artery going to the pulmonary trunk and lungs for the process of
oxygenation. In the lungs blood will release carbon dioxide and will be oxygenized. Blood will
pass through the pulmonary vein down to the left atria. From left atria the mitral valve will open
and will be drain down to the left ventricle. The left ventricle now will pump the oxygenated
blood towards the aortic valve ascending and descending aorta. The oxygenated blood is now
going to for the systemic circulation.
The movement of the blood through the heart is controlled by the opening and closing of
the valves and the contraction and relaxation of the myocardium. Coronary circulation delivers
oxygenated blood to myocardium and removes carbon dioxide from it. Deoxygenated blood
15
from the heat returns to the atria via coronary sinus. (See Figure 1.3)Malfunction of this system can
result to angina pectoris or myocardial infarction.
Figure 1.4 SA node and AV node
Conduction system of the heart
The conduction system of the heart consists of specialized cardiac muscle tissue that
generates and distributes action potential. Components of this system are the sinoatrial (SA) node
this is the peacemaker, and initiate the cardiac contraction by passing electric impulse to
atrioventricular (AV) node(See Figure 1.4),in which this node passes the electric impulse going to
the bundle of his. From the bundle of His electric impulse will pass through the purkenji fibers.
Thus, cardiac contraction happens.
16
PATHOPHYSIOLOGY(Patient based)
Figure 1.5 Pathophysiology (Patient-Based)
17
Figure 1.6 Pathophysiology(book based)
18
DEFINITION OF THE DISEASE
Heart muscle disease is called cardiomyopathy and is a problem with the physical shape
of the muscle. Often its origin is unknown. Cardiomyopathy is a serious condition that can lead
to heart failure, dysrhythmias and death.
SYNTHESIS OF THE DISEASE
RISK FACTORS (patient based)
 Genetic factor-if the person has a family history of heart diseases 20-30% possibility that
he/she will acquire that disease from them as it already runs on the genes. (Daniels 2010).
From the start a person with family history of cardiomyopathy has already a cardiac
abnormalities and its unknown if this will progress to full cardiomyopathy to later life.
There is a presence of disease genes (dystrophin, tatazzin, cardiac actin, desmin, Lamin
A/C, delta-sarcoglycan, cardiac beta myocin heavy chain, and cardiac troponin T-gene).
The mutation in Lamin A/C is the one that causes cardiomyopathy. Other mutations are
the cause in addition skeletal muscle myopathy. Dystrophinmutation are the cause of the
rare X-linked dilated cardiomyopathy without skeletal muscle involvement and a
progressive course in young men. Other mutation in dystrophin gene, mainly deletion ,
are the cause of muscular dystrophy Becker and Duchenne which are also present in
dilated cardiomyopathy.
 Age-the higher the age of a person the higher the risk for heart diseases because of the
degeneration of the tissues. And the presence of atherosclerotic disease that usually
occurs in the late stage of life. This atherosclerosis causes a strain in the heart muscle
because of compensatory mechanism of the body usually being a tachycardic.
 Gender- male is more prone to having cardiac related diseases than the female because of
the vices (smoking, drinking). This activity causes the destruction and toxicity of cells in
the heart.
PRECIPITATING FACTOR
 Smoking- cigarrete containa chemical nicotine that is responsible in the hardening of the
arteries that causes increase workload in the heart that may lead to myocardial disease or
heart failure. While the carbon monoxide toxicity causes the heart to weakens.
19
 Respiratory infection- bacterial infection causes increase in secretion causing coughing
and increase in oxygen demand leading to a compensatory mechanism of the body such
as increase in heart rate and respiratory rate.
 easy fatigability s being experienced because of the increase in oxygen demand
 cough because of the reaction of bacterial infection in the RR system
 Pulse deficit most possible is because of the medication specifically the Digoxin.
SIGNS AND SYMPTOMS (patient based)
Signs and symptoms Rationale
Fever
The high temperature of the patient is caused
by respiratory infection by the inflammation of
the tracheal and bronchial area, due to
pathogenic invasion. The inflammation will
cause releasing of pyrogens from cells. These
endogenous pyrogens will stimulate the release
of prostaglandin that will trigger the
hypothalamic thermostat to higher temperature.
Hypertension
Or high blood pressure. It is because of
decrease vascular regulation(atherosclerosis)
resulting from malfunction of arterial blood
flow due to formation of clots. And then there
would be elevated blood pressure that will lead
to increased heart rate.
Easy fatigability
Due to continuous exertion of heart and
increase in oxygen demand. It will cause an
overuse stage and eventually the body will
experience of feeling weakness, tiredness and
listlessness.
Impaired gas exchange
Due to myocardial dysfunction secondary to
decrease mayocardial contraction there would
be an abnormal perfusion. That explains the
amount of blood ejected from left ventricle
diminished and the heart cannot pump enough
blood to meet body needs. It will cause limited
airflow which leads to decreased cardiac
output.
Activity intolerance
Due to long term HPN and irregular cardiac
pattern there is an impaired heart muscle
resulting to decrease its capacity to function
normally also resulting to decrease blood
volume and oxygen in the systemic circulation
causing easy fatigability
20
Nail and skin color changes
Decrease cardiac output and decrease arterial
perfusion will cause abnormal process of
circulation to a capillary bed in blood tissue
that affects the skin color changes and the
extremities.
Abnormal urine output
-Decrease cardiac output and decrease RBC
will cause R-A-A stimulation. It means that
there is re-absorption of sodium and water in
the blood. It will bring about by fluids and
electrolytes imbalances.
-Due to decrease kidney function there is an
improper absorption of water and wastes from
the blood stream.
Edema
Due to decrease kidney function and R-A-A
stimulation the retention of too much salt
causes the body to retain water. This water
then leaks into the interstitial tissue space. This
is what we call edema.
TREATMENT
DIAGNOSTICS AND LABORATORY PROCEDURES
General nursing responsibilities
 Check doctors order
 Explain to the client the importance of the test and what it is for
ECG
Before
 Remove all metals attached to the body
 Make sure your health care provider knows about all the medications you are taking, as
some can interfere with test results.
 Exercising or drinking cold water immediately before an ECG may cause false results.
 An ECG is painless. No electricity is sent through the body. The electrodes may feel cold
when first applied. In rare cases, some people may develop a rash or irritation where the
patches were placed.
21
During
 You will be asked to lie down. The health care provider will clean several areas on your
arms, legs, and chest, and then attach small patches called electrodes to the areas. It may
be necessary to shave or clip some hair so the patches stick to the skin. The number of
patches used may vary.
 The patches are connected by wires to a machine that turns the heart's electrical signals
into wavy lines, which are often printed on paper. The test results are reviewed by the
doctor.
 You usually need to remain still during the procedure. The health care provider may also
ask you to hold your breath for a few seconds as the test is being done. Any movement,
including muscle tremors such as shivering, can alter the results. So it is important to be
relaxed and relatively warm during an ECG recording.
 Sometimes this test is done while you are exercising or under minimal stress to monitor
changes in the heart. This type of ECG is often called a stress test.
After
 Remove the patches slowly
Diagnostic/laboratory
procedure
Date
ordered:
July 7,
2012
General
description
Indication
or
purpose
Result Normal
values
Analysis and
interpretation
ECG Date
result in:
July 7,
2012
Standardized
recording of
electrical activity
of the heart
To detect
cardiac
ischemia
and
abnormal
rhythms.
PR-0.30
seconds
QRS-0.06
seconds
QT-0.26
seconds
PR-0.12-
0.20 sec
QRS-0.06-
0.12 sec
QT-0.32-
0.44 sec
The PR wave
wasprolong.
The QRS is
normal.
The QT is
shorter than
normal.
URINE TEST
Before
 Instruct the patient to void directly into a clean, dry container. Sterile, disposable
containers are recommended.
22
During
 Cover all specimens tightly, label properly and send immediately to the laboratory.
 If a urine sample is obtained from an indwelling catheter, it may be necessary to clamp
the catheter for about 15-30 minutes before obtaining the sample. Clean the specimen
port with antiseptic before aspirating the urine sample with a needle and a syringe.
After
 Observe standard precautions when handling urine specimens.
 If the specimen cannot be delivered to the laboratory or tested within an hour, it should
be refrigerated or have an appropriate preservative added
Diagnostic/labo
ratory
procedure
Date ordered:
July 7 2012
General
description
Indicatio
n or
purpose
Result Normal
values
Analysis and
interpretatio
n
URINE TEST Date result
in:
July 7 2012
Urine test is a
test where in
urine is being
collected to
examine in a
microscope
To
determine
the proper
function
of the
kidney
Color-yellow
Transparency-
clear
PH-4.0
Specific
gravity-1.020
Albumin-trace
Sugar-negative
Pus cels-HPF-
2.4
RBC/HPF-2.4
Epithelial
cells-few
A.urates- few
Color-
yellow
Transparency-
clear
PH-4.6-8
Specific
gravity-
1.003-1.025
Albumin-
Sugar-Nil
Pus cells-
RBC-1-
02/low
power field
1/ high
power field
Epithelial
cells, and A
urates can
be found in
the urates in
a few
number
Color is normal
Transparency
normal
PH- is in
normal range
Specific
gravity-is in
normal range
No sugar found
indicating its
normal
RBC is slightly
above the
normal range
And it is
normal for the
epithelial and A
urates to be
found in the
urine providing
in a few
number.
BLOOD TEST
Before
 Nurses must help position patients properly, like rolling the patient over, in order to
complete the necessary diagnostic testing.
23
 Check a patient's vital signs (blood pressure, pulse, breathing rate), assess physical
condition and keep an eye on any monitors that the patient needs to remain hooked
up to during the tests, such as a heart monitor or ventilator. Nurses may also be
required to connect or disconnect any monitors or devices that can interfere with the
testing.
During
 Draw the sample before giving or one hour after giving I.M. injections. I.M. injections
will increase the total CK level.
 Be sure to obtain the blood samples on schedule. Always note on the laboratory slip, the
time the sample was drawn and the hours elapsed since onset of chest pain. Be sure to
draw blood samples in a 7-ml red top tube.
 Be sure to handle the sample gently to prevent hemolysis. Always have the sample
transported to the lab promptly because CK activity diminishes significantly after 2 hours
at room temperature.
After the procedure
 Apply cotton ball with slight pressure to the site to bleeding.
 Test results are reported to the patient's doctor, specialists and others in need of the
information by nurses. Results may be phoned in, faxed or sent electronically via a
computer. It may be the nurse's responsibility to check for the results of the tests as well.
They may be in charge of entering the results into the patient's medical record. Nurses
must also notify the patient's physician when abnormal or critical results that require an
immediate response, such as abnormal blood work with critical potassium levels, are
found.
Diagnostic/labo
ratory
procedure
Date ordered:
July 7 ,2012
General
descriptio
n
Indicatio
n or
purpose
Result Normal
values
Analysis and
interpretatio
n
Blood test Date result
in:
July 7, 2012
Blood
chemistry
Give
specific
informatio
n about
the
condition
of your
organs.
RBS-6.88
BUN-4.0
Createnine-
98.3
CK-MB-8.18
Troponin I-Nil
RBS-3.85-
9.0mmol/l
BUN-1.7-
8.3mmol/l
Createnine-
60-
120mmol/l
CK-MB-0-
RBS is in
normal range
BUN is in
normal range
CREATENIN
E is in normal
range
CK-MB is
24
Sodium-141.9
Potassium-
3.45
Hemoglobin-
144
Hematocrit-43
WBC-11.4
Neutrophils-.7
Platelet count-
248
25IV/l
Troponin-
Nil
Sodium-
135-
145mmol/l
Potassium-
3.5-
5.5mmol/l
Hemoglobi
n-125-
175mmol/l
Hematocrit-
0.40-0.52
WBC-5-
10x10/l
Neutrophils
-0.45-0.65
Platelet
count-150-
400x10?l
isnormal
range
There is no
troponin I
found
SODIUM is
in normal
range
POTASSIU
M is slightly
low
HEMOGLOB
IN is in
normal range
HEMATOCR
IT is in
normal range
WBC is
slightly
elevated
NEUTROPHI
LS is in
normal range
PLATELET
COUNT is in
normal range
Diagnostic/labo
ratory
procedure
Date ordered:
July 7, 2012
General
descriptio
n
Indicatio
n or
purpose
Result Normal
values
Analysis and
interpretatio
n
Blood test Date result
in:
July 7 2012
HEMATOL
OGY
To
determine
the total
volume of
blood
HGB-143
WBC-8.8
RBC-5.0
HCT-0.43
HGB-140-
180gm/l
WBC-5-
10x10mo/l
RBC-4.5-
6.3x10/l
HCT-0.40-
0.54L/L
HGB is in
normal range
WBC is in
normal range
RBC is in nor
mal range
HCT is in
normal range
25
Diagnostic/labo
ratory
procedure
Date ordered:
Date result
in:
General
descriptio
n
Indicatio
n or
purpose
Result Normal
values
Analysis and
interpretatio
n
Blood test July 7 2012 Chemical
chemistry
To
determine
the proper
function
of the
heart
BUN-2.8
CREATENIN
E-70.8
SODIUM-
143.8
POTASSIUM-
3.55
BUN-2.1-
7.1mmo1/l
CREATENI
NE-62-
106mmol/l
SODIUM-
135-
148mmol/l
POTASSIU
M-3.5-
5.3mmol/l
BUN,
CREATENIN
E, SODIUM,
POTASSIUM
are all in
normal
range
IVF
Before
 Lean the site with cotton balls with alcohol
During
 Make sure to maintain bed rest
 Continues cardiac monitoring
 Report any abnormal findings to the physicians
 Increase the rate of infusion as prescribe, but monitor for fluid overload
 No evidence of dehydration should be noticed
 Check the IV site for redness, swelling and infiltration
After
 Apply cotton balls to the site to prevent bleeding
MEDICAL
MANAGEMENT
Date ordered:
July 7
Date started:
July 7
Date
Changed:
July 8
GENERAL
DISCRIPTION
INDICATION
PORPOSE
CLIENT’S
RESPONSE
1ST
D5LRS 1LxKVO
D5LRS are fluids
which are intended to
be administered
because hypertonic
solution are those that
have an effective
osmolarity greater than
the body fluids.
This pulls thefluids
into thevascular by
osmosis resulting in an
increase vascular
volume .It raises
intravascular osmotic
pressureand provides
fluid, electrolyteand
calories for energy.
Client maintain fluid
balance despiteof
strict monitoring of
I&O
26
O2 THERAPHY
Before
 Instruct the client and visitors about the hazard of smoking with oxygen use.
 Make sure that electric devices (such as razors, hearing aids, radios, televisions, and
hearing pads) are in good working order to prevent the occurrence of short-circuit sparks.
Ensure proper delivery method (cannula, face mask, face tent)
 Teach client proper use of oxygen
During
 Avoids materials that generate static electricity, such as woolen blankets and synthetic
fabrics. Cotton blankets should be used, and client and caregivers should be advised to
wear cotton fabrics.
 Regulate flow if necessary
After
 Always make sure that the oxygen tank is properly closed
MEDICAL
MANAGEMENT
Date ordered
July 7, 2012
Date started
July 7, 2012
GENERAL
DESCRIPTION
INDICATION
PORPOSE
CLIENT’S
RESPONSE
OXYGEN 1-2
liter/min
Oxygen is a
colorless gas that
exists in the air that
all living things
needed in order to
live.
To provide enough
oxygen despite of
difficulty of
breathing
Patient was relieved
experiencing DOB
DRUGS
General nursing responsibilities
Before
 Check doctor’s order
 Explain to the patient what the medication is for. During:
During
 Give the medication on time.
After:
27
 Document the medication done.
CEFTRIAXONE
Before
 Read carefully the name cephalosporin’s have similar sounding and similar spelled
names.
 Reconstitute 1 mL of cephalosporin to 5 mL of sterile water.
Determine allergy to the cephalosporin through skin testing.
During
 Do no infuse rapidly, it causes pain and irritation
Name of the
drug:
Date ordered:
July 7, 2012
Route:
IV infusion
General
action
Indication Clients response to the actual
adverse reaction
Date started:
July 7, 2012
3rd generation
cephalosporin
antibiotic
Lower
respiratory
infection due
to pneumonia
The client did not manifest any
S&S of infection
Generic
name:
Ceftriaxone
sodium
Dosage and
frequency:
1 gm Q12
Brand name:
Rocephin
Date
discontinued:
July 9, 2012
FUROSEMIDE
Before
 Do not confuse Lasix with Lanoxin (a cardiac glycoside)
 Asses closely for a sign of vascular thrombosis and embolism.
 Take Blood Pressure before administering the medication give IV injection slowly, may
cause pain and irritation.
During
 Do not infuse rapidly
After
 For rapid diuresis observe for dehydration.
 Assess for S and Sx for hyperkalemia.
 Let the client change the position from lying to sitting the stand slowly.
 Supplement diet with vegetable and fruits that are high in potassium. (ex. Bananas,
peaches and oranges.)
28
Name of the
drug:
Date ordered:
July 7, 2012
Route:
IV bolus
General
action
Indication Clients response to the actual
adverse reaction
Date started:
July 7, 2012
Loop Diuretic Edema There was in increase in urine
output from 45cc in 2 hrs. to
300cc in 5 hrs.Generic
Name:
Furosemide
Dosage and
frequency:
40 mg
Q 6°
(12 , 6)
Brand
Name:
Lasix
Date
discontinued:
July 8 2012
AMIODARONE HYDROCHLORIDE
Before
 Correct potassium and Magnesium
During
 Follow recommended dietary guidelines. Avoid or limit salt and fluid as directed. Avoid
grape fruit.
After
 Record BP and pulse for providers review. Identify specific levels to hold drugs. HR <60,
BP <90/60.
Name of the
drug:
Date
ordered:
July 7
Route:
Oral
General
action
Indication Clients response to the
actual adverse reaction
Date started:
July 7 Antiarrhytmic Prolong the
duration of the
membrane
action
potential(relative
refractory
period) without
the change the
phase of
depolarization or
the resting
action
membrane
potential.
The client maintains a
normal heart rate of 73 bpm
Generic
Name:
Amiodarone
Hydrochloride
Date
discontinued:
July 9, 2012
Dosage and
frequency:
O.D.
( 8 )
Brand Name:
Cordarone,
Pacerone
29
LOSARTAN POTASSIUM
Before
 Do not confuse Lozaar with Zocor (Antihyperlipidimic) .
 Take pulse rate and BP before administering medication.
After
 Low fat, low sodium diet and avoid grape fruit.
 Do not change position suddenly.
Name of the
drug:
Date
ordered:
July 7, 2012
Route:
Oral
General action Indication Clients response to the
actual adverse reaction
Date started:
July 7, 2012
Date
discontinued:
July 9, 2012
Antihypertensive,
Angiotensin II
receptor blocker
Antihypertensive,
alone or with
combination with
other
antihypertensive
drugs(including
diuretics).
Reduces risk of
stroke in clients
with
hypertension and
left ventricular
hypertrophy.
The patient maintains a
normal blood pressure of
110/70 mmhg
Generic
Name:
Losartan
Potassium
Dosage and
frequency:
50 mg
(8 )Brand
Name:
Lozaar
LEVOFLOXACIN
Before:
 Check if patient is able to swallow or in need of NGT.
 Prepare the medication and other materials to be used.
Name of the
drug:
Date
ordered:
July 7, 2012
Route:
Oral
General action Indication Clients response to the
actual adverse reaction
Date started:
July 7, 2012
Date
discontinued:
July 9, 2012
Flouroquinolone
Antibiotic
5 day
treatment
regimen for
community
acquired
pneumonia
due to
Streptococcus
The patient prevent further
infectionGeneric
Name:
Levofloxacin
Dosage and
frequency:
Oral
(8 )Brand
Name:
Levaguin,
30
Quixin Pneumoniae.
DIGOXIN
Before
 Monitor bradycardia/ arrhythmias, count apical rate for atleast one minute. Before
administering.
 Have digoxin immune FAB available
After
 Monitor for pulse deficit. (It indicates adverse drug reaction.)
 For severe toxicity.
 Use caution: Digoxin withdrawal may worsen heart failure.
 Take at the same time each day.
 Do not change brands.
Name of the
drug:
Date
ordered:
July 7, 2012
Route:
Oral
General
action
Indication Clients response to the actual
adverse reaction
Date started:
July 7, 2012
Date
discontinued:
July 9, 2012
Cardiac
Glycoside
Propylaxis
and treatment
of recurrent
paroxysmal
AV junction
rhythm.
The patient maintains a normal
heart rate of 73 bpm
Generic
Name:
Digoxin
Dosage and
frequency:
25 mg
( 8 )
Brand
Name:
Lanoxin
POTASSIUM CHLORIDE
Before
 Obtain renal function test, dysfunction leads to hyperkalemia.
 Prepare the medication.
During
 Do not draw or dissolve in the mouth.
 Monitor I/O.
After
31
 Report any sign of weakness, fatigue or cardiac arrhythmias, it is a sign of hypokalemia.
 Record the medication done.
 Monitor input/output
Name of the
drug:
Date
ordered:
July 7. 2012
Route:
Oral
General
action
Indication Clients response to the actual
adverse reaction
Date started:
July 7, 2012
Date
discontinued:
July 9, 2012
Electrolytes
Hypokalemia
with or
without
metabolic
acidosis
following in
increase
urinary
excretion.
The client maintains a normal
level of K of 3.55Generic
Name:
Potassium
Chloride
Dosage and
frequency:
O.D.
(8 )Brand
Name:
KaliumDurule
CALCIUM GLUCONATE
Before
 Do not administer together with other medication
 Make sure provider is aware of all the medication prescribed.
Name of the
drug:
Date
ordered:
July 7,2012
Route:
IV
General
action
Indication Clients response to the actual
adverse reaction
Date started:
July7, 2012
Date
discontinued:
July 8, 2012
Calcium salt
Prophylaxis
of
hypocalcemia
during
exchange
transfusion
The client maintains a normal
level calcium in the bloodGeneric
Name:
Cagluconate
Dosage and
frequency:
1 ampule
STATBrand
Name:
Cal-G
MAGNESIUM SULFATE
Before
 Asses for absent patellar reflex, <100ml in for hr urine output
 Asses for Sign and symptoms of hypermagnesemia (flushing, sweating, hypotension or
hypothermia)
Name of the Date Route: General Indication Clients response to the
32
drug: ordered:
July 7,2012
IV
action actual adverse reaction
Date started:
July 7, 2012
Date
discontinue:
July 7, 2012
Miscellaneous,
essential
element for
muscle
contraction,
certain
enzyme, and
nerve
transmission
Replacement
therapy in Mg
deficiency
especially in acute
hypomagnesaemia
accompanied by
signs of tetany
similar to those
seen in
hypocalcemia
The client maintains
normal HRGeneric
Name:
Magnesium
sulfate
Dosage and
frequency:
2 gram
STAT
Brand
Name:
Epsom salt
ASPIRIN
Before
 Have epinephrine available to counter act hypersensitivity occurs
 Note history of peptic ulcer or bleeding tendencies
During
 Take with full glass of water to prevent lodging in esophagus
After
 Inform the patient to report ringing in the ear, difficulty hearing, dizziness or fainting
spells, unusual increase in sweating, severe abdominal pain or mental confusion (this is a
sign of a toxic effect)
Name of the
drug:
Date
ordered:
July 7,2012
Route:
Oral
General
action
Indication Clients response to the
actual adverse reaction
Date started:
July 7, 2012
Date
discontinued:
July 7, 2012
Inhibit
platelet
aggregation
Use for
cardiovascular
disease
Patient prevents platelet
aggregation
Generic
Name:
Acetylsalicylic
Acid
Dosage and
frequency:
80 mg
OD
Brand Name:
Aspirin
DIET
Before
33
 Check the doctor’s order. Question for any inconsistencies regarding patient’s diet and
condition
 Explain the importance of diet prescribed
After
 Document intake as to amount and provide a separate sheet for fluid and output
 Take note of patient’s response to the diet
ACTIVITY
BED REST
Before
 Explain to the patient why it is necessary
 Inform the patient to wear pressure stocking and explain why it is necessary
During
 Always make sure that there is somebody with him to assist his needs
 Make sure your patient is changing position at least every two hours as permitted by her
doctor to avoid bed sores that will put her into risk of impaired skin integrity related to
immobility.
 Always elevate the bedrails
After
 Let the client stand or move in a gradual motion
MEDICAL
MANAGEMENT
Date ordered:
July 7, 2012
GENERAL
DISCRIPTION
INDICATION
PURPOSE
CLIENT’S
RESPONSE
TYPE OF DIET GENERAL
DESCRIPTION
INDICATION/PURPOSE SPECIFIC FOOD
TAKEN
LFLS Low fat and low sodium
diet
To prevent the further
accumulation of
atherosclerotic plaque that
will contribute to increase
workload of the heart.
pineapple
Soft diet Fluid or soft food To prevent constipation
that may stimulate the
vagus nerve and lead to
heart failure.
Water, arozcaldo
34
Bed Rest
Date started:
STAT
A medical treatment
involving a period of
consistent (day and
night) recumbence in
bed and
Reducing activities.
Prevent any
restraints that can
cause easy
fatigability and
further problem to
the heart
The patient was
cooperative and
reduces the feeling
of easy
fatigability.
DAILY PATIENT’S RECORD/EVALUATION
Days Admission-Day 1(July 7,
2012)
Day 2(July 8, 2012)
Nursing problems Cough, easy fatigability Easy fatigability
Vital signs BP-110/70, RR-17, PR-78,
Temp-36°
BP-110/70, RR-24, PR-53,
Apical-78, Temp-36.2
laboratory Hematology, chemical
chemistry, urinalysis, blood
chemistry, electrolytes
None
IVF, O2 D5LRS 10 gtts (KVO) O2-2
LPM
#2 D5LRS D5LRS 10 gtts
(KVO) O2-2 LPM
Drugs Ceftriaxone 1 gm q12°,
furosemide 40 mg IV q6°,
MgSO4 2 gm IV STAT,
Cagluconate 1 amp IV STAT,
amiodarone 200 mg OD,
Losartan 50 mg 1 tab OD,
Lanoxin 25 mg 1/2 tab OD,
levofloxacin 500 mg 1 tab
OD, kaliumdurule 1 tab BID,
aspirin 80 mg 1 tab OD
Levofloxacin500 mg 1 tab
OD, , lanoxin25 mg 1/2 tab
OD, kaliumdurule, furosemide
40 mg IV q6°, ceftriaxone1
gm q12°,, losartan50 mg 1 tab
OD, Kalium durule1 tab BID ,
amniodarone 200 mg OD
Diet NPO LFLS
Activity Bed rest Bed rest
35
DISCHARGE PLANNING
Strategy Objective Content Time frame Resources
Deep
breathing
exercises
To improve
the lung
capacity thus
decreases the
workload of
the heart
DeepBreathing Exercises
Deep breathing is a
relaxation technique that can
be self-taught. Deep
breathing releases tension
from the body and clear the
mind, improving both
physical and mental
wellness.
We tend to breathe
shallowly or even hold our
hold our breath when we are
feeling anxious. Sometimes
we are not even aware of it.
Shallow breathing limits
your oxygen intake and adds
further stress to your body,
creating a vicious cycle.
Breathing exercises can
break this cycle
How to do DeepBreathing
Exercises:
1.Sit up straight. (Do not
arch your back) First exhale
completely through your
mouth.
2.Place your hands on your
stomach, just above your
waist.
2.Breathe in slowly through
your nose, pushing your
hands out with your
stomach. This ensures that
you are breathing deeply.
3.Imagine that you are
Every time
necessary
Teaching and
demonstration
36
filling your body with air
from the bottom up.
4.Hold your breath to a
count of two to five, or
whatever you can handle. It
is easier to hold your breath
if you continue to hold out
your stomach.
5.Slowly and steadily
breathe out through your
mouth, feeling your hands
move back in as you slowly
contract your stomach, until
most of the air is out.
Exhalation is a little longer
than inhalation.
6.After you get some
experience you don’t need to
use your hands to check
your breathing.
You can also do the above
breathing exercise lying on
your back. Deep breathing
exercises can help you to
relax before you go to sleep
for the night, or fall back
asleep if you awaken in the
middle of the night.
You can also practice deep
breathing exercises standing
– e.g. while sitting in traffic,
or standing in a lineup at the
grocery store. If you are
really tense and feel as if
you are holding your breath,
simply concentrate on
slowly breathing in and out.
37
Strategy Objective Content Time
frame
Resources
Early
Ambulation
To improve
cardiac
muscles and
improve its
function
Safety tips for Stair Climbing
Safety and effective climbing
should be your goal for stair
climbing. The following safety
tips can help you start an
effective stair climbing regime:
 Keep people informed
about stair climbing
whether at office or
home.
 Always carry water or
fluids with you.
 Be aware of your knee
alignment as it can cause
a knee or ankle sprain.
 Inspect the stairs before
climbing them as an
exercise.
 Watch out for opening
doors at the end of the
stairway.
What is the Ideal Way to
Start Stair Climbing?
Any aerobic exercise should be
started very slowly and
gradually. The ideal form of
any exercise or stair climbing
should take care of the
following:
 1. 5-15 minutes of warm up
exercises are absolutely
Once a day Health teaching
38
essential for starting
anyworkout session

 2. Start climbing with gradual
slow steps.

 3. You can alternate
between quicker and low step
routines andslower and deep
step routines.
 4. Finally, relax and
cool yourself down.

Control the intensity of your
exercise and do not over-exert
yourself in your first and initial
attempt. Set a goal for yourself
like increasing the pace by
one flight of stair per week
Strategy Objective Content Time frame Resources
Low fat
Low
sodium Diet
To avoid the
formation of
atherosclerotic
plaque
By following such diet, the
risk of heart disease,
gallbladder disease,
diabetes, and even some
forms of cancer is greatly
reduced. It is also a great
way to lose weight.
Throughout
the day
Health
teachings
39
Example of a low fat low
sodium diet
Breakfast-scramble egg,
diced mushroom and red
and green peppers, oatmeal
with a sliced banana
Lunch- fresh fruits and
vegetables salad with baked
fish or chicken on top
Dinner- boiled fresh
vegetables
All you need is 30 minutes of
moderate-level physical
activity on most days of the
week. Examples of such
activities are brisk walking,
bicycling, raking leaves, and
gardening.
Strategy Objective Content Time frame Resources
Moderate
active ROM
exercise
To prevent
sudden onset
of rapid
heartbeat
.Range-of-
motion
exercise
enhance
muscle
flexibility.
All you need is 20-30 minutes
of moderate-level physical
activity on most days of the
week.
Examples of such activities are
1.Chin to chest
2. Head turns
3. Head tilts
4. Shoulder movement, up and
30 minutes
everyday
Health
teachings
40
down
5. Shoulder rotation
6. Elbow bends up and down
7. Elbow bends side to side
8. Wrist rotation
9. Palm up, palm down
10. Finger bends
11. Finger spread
12. Hip and knee bend
13. Leg movement side to side
14. Leg rotation
15. Knee rotation
16. Ankle and toe bends
17. Ankle and toe rotation
41
NURSING CARE PLAN
EXCESS FLUID VOLUME
42
INEFFECTIVE BREATHING PATTERN
43
ACTIVITY INTOLERANCE
44
ACTIVITY INTOLERANCE
SUMMARY
Some people who have cardiomyopathy have no signs or symptoms and need no
treatment. For other people, the disease develops quickly, symptoms are severe, and serious
complications occur.
Treatments for cardiomyopathy include lifestyle changes, medicines, surgery, implanted
devices to correct arrhythmias, and a nonsurgical procedure. These treatments can control
symptoms, reduce complications, and stop the disease from getting worse
Cardiomyopathy is a common disease affecting more than 1 million people around the
world. There are so many contributing factors that trigger the onset of this cardiac disease. Based
on our patient some of these factors are (age, family history, gender, and history of smoking). It
is hard to predict if the person is when he/she is going to acquire the disease. Easy fatigability
45
and cough was the symptom why the patient admits himself in the hospital for he perceives that
it was a life threatening situation for her. Diagnostics was required to determine the exact
problem and the treatment is consists of combination of medication in order for his heart to
function on is normal. But this is not enough there should be a strict and continuous monitoring
of the patient status in order for the patient to recover faster.
RECOMMENDATION
Patient with or without a family history of cardiac disease (cardiomyopathy) should be
very cautious in terms of life style and should avoid the triggering factors that will cause this
disease to emerge. All people is risk to having different kind of diseases how much more of those
who have a history. Therefore we recommend that everyone should be concern and be
knowledgeable about things that are needed to do. As a student nurses it is our responsibility to
enforce teachings that will maintain or at least prevent the occurrence of problem and thus it will
help create a healthy community.
LEARNING DERIVED
Policarpio, Jeffrey S.
ICU is the second rotation I had since starting my clinical duty. Compared to delivery
room, ICU is more in depth when it comes to giving patient care. Due to the time spent with
patient, I was able to develop other nursing care skills. I was able to practice my skills with
compassion due to prolonged time spent with patient.
Nursing is not just giving treatment; it is how you give care. As early as now, I am
learning to incorporate compassion with my chosen profession.
Familiarizing myself with patient’s chart, drug administration and utilizing different
hospital machines such as mechanical ventilator, ECG and atrial defibrillator, provided me with
understanding of nursing practice in a whole new level. With this rotation, I had gained more
awareness with the practice of infection control not just for me but especially for the patient.
Patients in ICU had to deal not just with their major diagnosis but also complications. In line
with this, practicing good handwashing, masking and maintaining cleanliness, is my way of
showing I care. In my mind, if I don’t practice infection control, this will expose my patients to
more medical problems mainly that their immune system is already compromised.
Delivery room is a fast paced environment. In ICU, it gives me more time to know not
just my patients’ medical problems but my patient as a person as well. My patients need me and
depend on me with their needs, thus, I need to show that they can count on me just to relieve
them a little bit of what they are going through. Moreover, in ICU, I need to give individualized
care which gave me the opportunity to learn more about different nursing interventions.
Critical thinking is always a part of nursing practice. My ICU experience gave me the
opportunity to practice this skill, taking into consideration the welfare of my patient, thus
showing that nurses are not just mechanical workers that move in a routine manner.
Nevertheless, nurses move with precise interventions and with compassion.
46
It will always be in my mind that in my chosen career, I deal with human beings. These
human beings, sometimes needs machines to survive in ICU, but it will make a big difference if
a nurse incorporates love when using those machines with them. And for sure, the patient will
know the difference of a nurse who provides interventions just for the heck of it and a nurse who
moves with passion and care.
ROWENA P. LIGON
Being in the ICU is a challenging experience a student nurse will acquire. Having an
actual patient is very crucial part in the studies of a student nurse. This is the time of realization
that life of a person is at risk if the person that will handle that patient is not equipped with
knowledge on how to handle a patient.
Knowing the Patient that as a student nurse will provide an assessment in the ICU is a
very important step. The student nurse should know to protect the privacy and the integrity of
the patient assigned to him/her. The student nurse will not only base his/her analysis from the
questions and assessment being conduct to his assigned patient, but rather to gather all the
necessary data from other sources like the laboratory results, genogram that will support to have
accurate case study.
IRISH SANTOS
Data collection, assessment taken, is where everything must start, because if a student
nurse fail to determine the needs of the patient, there will be a failure to the speedy recovery of
his Patient. Communicating skills is also a very crucial stage of assessment for a student nurse to
be able to gain their trust you must establish rapport.
Health teaching is very necessary due to lack of knowledge to some patient. Teaching them
the importance of seeking immediate help when they feel that something is wrong to them, in
order to treat the problem immediately. We have to be cautious enough about our health to live
longer and be with our love ones.
Like the famous saying: “Health is wealth”.Being free from disease is to live a healthy
lifestyle. It is up to the person how they will utilize the resources around them.
47
MARY LEZ D. PERRY
Though it was my first time to be assign in the ICU I learned so many things that a
student nurse should know. Some of it was very unfamiliar to me, like the negatoscope, the
solucet, and it was my first time to observed somebody doing a sunctioning. I was able to
understand how ECG is being apply to the chest. I was I able to understand what the lines mean
in the ECG result. It was my first time to administer lantus to a patient. It was a very nice
experience taking care of the patient. I was able to observe what could be a patient would ned in
the situation where in nobody want to be.
MARK OLIE B. LAYAG
Being in ICU, the first thing that comes in my mind are those patients who are in critical
condition. Having an actual patient is very crucial part in the studies of a student nurse. . I felt
very nervous because I don’t know what I will expect in ICU and what are the things should be
done.
You are going to analyze an ethical conflict and come up with a course of action that is
morally defensible and medically reasonable. And assist patients and their families at time of
critical illness with respect, concern for their dignity, and careful attention to pain control and
suffering.
The most I learned is to how to prioritize the needs of the patients. On how to be attentive
on monitoring because we know that these patients need to be closely monitored because of their
situation.
48
REFERENCES
MEDICAL SURGICAL (CONCEPTS AND CLINICAL APPLICATION) 2ND EDITION
2009
JOSIE QUIAMBAO UDAN
NURSE’S POCKET GUIDE (DIAGNOSES INTERVENTIONS AND RATIONALES
MARILYN E. DOENGES, MARY FRANCES MOORHOUSE, ALICE C. MURR
POCKET NURSES’ DICTIONARYBY GUPTA
CONTEMPORARY MEDICAL-SURGICAL NURSING VOLUME 1
RICK DANIELS, LAURA NOSEK, LESLIE NICOLL
DELMAR’S NURSE’S DRUG HANDBOOK 2010 EDITION
GEORGE r. SPRATTO, ADRIANNE l. WOODS
NURSE’S HANDBOOK OF HEALTH ASSESSMENT SIXTH EDITION
WILLIAM &LIPPINCOT
INTRODUCTION TO THE HUMAN ANATOMY 7TH EDITION
TORTORA & DERRICKSON

More Related Content

What's hot

Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery diseaseHarivansh Chopra
 
Dm and kidney August 23 2019
Dm and kidney August 23 2019Dm and kidney August 23 2019
Dm and kidney August 23 2019Ala Ali
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...MedicineAndHealthUSA
 
Diabetic Kidney Disease
Diabetic Kidney DiseaseDiabetic Kidney Disease
Diabetic Kidney Diseasedrsanjaymaitra
 
Gpc manejo de enfermedades glomerulares-kdigo-2021
Gpc manejo de enfermedades glomerulares-kdigo-2021Gpc manejo de enfermedades glomerulares-kdigo-2021
Gpc manejo de enfermedades glomerulares-kdigo-2021WilliamBarrera34
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?ahvc0858
 
Epidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular DiseasesEpidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular DiseasesSarinkumar P S
 
Ngal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence asNgal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence asMoustafa Rezk
 
Clinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young AdultsClinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young AdultsPremier Publishers
 
Managing stroke risk in AF - best practice
Managing stroke risk in AF - best practiceManaging stroke risk in AF - best practice
Managing stroke risk in AF - best practiceNHS Improving Quality
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesChristos Argyropoulos
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Christos Argyropoulos
 
Care of patients with diabetic kidney disease
Care of patients with diabetic kidney diseaseCare of patients with diabetic kidney disease
Care of patients with diabetic kidney diseaseJimRitchie14
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEHMO Research Network
 

What's hot (19)

Kdigo 2012 ckd_gl
Kdigo 2012 ckd_glKdigo 2012 ckd_gl
Kdigo 2012 ckd_gl
 
Epidemiology of coronary artery disease
Epidemiology of coronary artery diseaseEpidemiology of coronary artery disease
Epidemiology of coronary artery disease
 
Dm and kidney August 23 2019
Dm and kidney August 23 2019Dm and kidney August 23 2019
Dm and kidney August 23 2019
 
Newer antiepileptic
Newer antiepilepticNewer antiepileptic
Newer antiepileptic
 
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...Hypertension and Diabetic Kidney Disease Progression 	 Hypertension and Diabe...
Hypertension and Diabetic Kidney Disease Progression Hypertension and Diabe...
 
Sex after acute myocardial infarction(Heart attack)
Sex after acute myocardial infarction(Heart attack)Sex after acute myocardial infarction(Heart attack)
Sex after acute myocardial infarction(Heart attack)
 
Diabetic Kidney Disease
Diabetic Kidney DiseaseDiabetic Kidney Disease
Diabetic Kidney Disease
 
Gpc manejo de enfermedades glomerulares-kdigo-2021
Gpc manejo de enfermedades glomerulares-kdigo-2021Gpc manejo de enfermedades glomerulares-kdigo-2021
Gpc manejo de enfermedades glomerulares-kdigo-2021
 
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
Cardiac Stress Test vs CT Coronary Angiogram: Which is better?
 
Epidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular DiseasesEpidemiology of Cardiovascular Diseases
Epidemiology of Cardiovascular Diseases
 
Advanced Cardiac Disease
Advanced Cardiac DiseaseAdvanced Cardiac Disease
Advanced Cardiac Disease
 
Ngal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence asNgal ,cystatin c versus creatinine clearence as
Ngal ,cystatin c versus creatinine clearence as
 
Clinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young AdultsClinical Profile of Acute Coronary Syndrome among Young Adults
Clinical Profile of Acute Coronary Syndrome among Young Adults
 
Managing stroke risk in AF - best practice
Managing stroke risk in AF - best practiceManaging stroke risk in AF - best practice
Managing stroke risk in AF - best practice
 
Sglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseasesSglt2 across the_spectrum_of_kidney_diseases
Sglt2 across the_spectrum_of_kidney_diseases
 
Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)Update on Diabetic Nephropathy (2018)
Update on Diabetic Nephropathy (2018)
 
Care of patients with diabetic kidney disease
Care of patients with diabetic kidney diseaseCare of patients with diabetic kidney disease
Care of patients with diabetic kidney disease
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
 
Dr. Agrawal
Dr. AgrawalDr. Agrawal
Dr. Agrawal
 

Viewers also liked

222066369 clad-study-guide
222066369 clad-study-guide222066369 clad-study-guide
222066369 clad-study-guidehomeworkping9
 
177282932 huyssen-vs-gutierez
177282932 huyssen-vs-gutierez177282932 huyssen-vs-gutierez
177282932 huyssen-vs-gutierezhomeworkping9
 
221851595 case-1-dr-nanda
221851595 case-1-dr-nanda221851595 case-1-dr-nanda
221851595 case-1-dr-nandahomeworkping9
 
124805050 indifan-stock-market
124805050 indifan-stock-market124805050 indifan-stock-market
124805050 indifan-stock-markethomeworkping9
 
118681762 cross-road
118681762 cross-road118681762 cross-road
118681762 cross-roadhomeworkping9
 
125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-study125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-studyhomeworkping9
 
125224112 pil-cases-2-oct-26-2012-doc
125224112 pil-cases-2-oct-26-2012-doc125224112 pil-cases-2-oct-26-2012-doc
125224112 pil-cases-2-oct-26-2012-dochomeworkping9
 
119575608 19018679-fast-food-industry-in-india-a-study
119575608 19018679-fast-food-industry-in-india-a-study119575608 19018679-fast-food-industry-in-india-a-study
119575608 19018679-fast-food-industry-in-india-a-studyhomeworkping9
 
217588134 155424763-case-14-yahoo
217588134 155424763-case-14-yahoo217588134 155424763-case-14-yahoo
217588134 155424763-case-14-yahoohomeworkping9
 
123312276 business-communications
123312276 business-communications123312276 business-communications
123312276 business-communicationshomeworkping9
 
124049814 facebook-case-study
124049814 facebook-case-study124049814 facebook-case-study
124049814 facebook-case-studyhomeworkping9
 
125179846 balco-case-analysis-docx
125179846 balco-case-analysis-docx125179846 balco-case-analysis-docx
125179846 balco-case-analysis-docxhomeworkping9
 

Viewers also liked (13)

222066369 clad-study-guide
222066369 clad-study-guide222066369 clad-study-guide
222066369 clad-study-guide
 
177282932 huyssen-vs-gutierez
177282932 huyssen-vs-gutierez177282932 huyssen-vs-gutierez
177282932 huyssen-vs-gutierez
 
221851595 case-1-dr-nanda
221851595 case-1-dr-nanda221851595 case-1-dr-nanda
221851595 case-1-dr-nanda
 
124805050 indifan-stock-market
124805050 indifan-stock-market124805050 indifan-stock-market
124805050 indifan-stock-market
 
124157075 gb
124157075 gb124157075 gb
124157075 gb
 
118681762 cross-road
118681762 cross-road118681762 cross-road
118681762 cross-road
 
125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-study125321274 peritoneal-carcinomatosis-grand-case-study
125321274 peritoneal-carcinomatosis-grand-case-study
 
125224112 pil-cases-2-oct-26-2012-doc
125224112 pil-cases-2-oct-26-2012-doc125224112 pil-cases-2-oct-26-2012-doc
125224112 pil-cases-2-oct-26-2012-doc
 
119575608 19018679-fast-food-industry-in-india-a-study
119575608 19018679-fast-food-industry-in-india-a-study119575608 19018679-fast-food-industry-in-india-a-study
119575608 19018679-fast-food-industry-in-india-a-study
 
217588134 155424763-case-14-yahoo
217588134 155424763-case-14-yahoo217588134 155424763-case-14-yahoo
217588134 155424763-case-14-yahoo
 
123312276 business-communications
123312276 business-communications123312276 business-communications
123312276 business-communications
 
124049814 facebook-case-study
124049814 facebook-case-study124049814 facebook-case-study
124049814 facebook-case-study
 
125179846 balco-case-analysis-docx
125179846 balco-case-analysis-docx125179846 balco-case-analysis-docx
125179846 balco-case-analysis-docx
 

Similar to 175972614 cardiomyopathy-mary

Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2Andrew Kwami
 
Part 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPPart 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPasadsoomro1960
 
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdfKs doctor
 
Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010Law Firm
 
need_for_medical__device_for_older_people
need_for_medical__device_for_older_peopleneed_for_medical__device_for_older_people
need_for_medical__device_for_older_peopleYasoba Atukorale
 
CCO_CLD_in_T2D_Downloadable_1.pptx
CCO_CLD_in_T2D_Downloadable_1.pptxCCO_CLD_in_T2D_Downloadable_1.pptx
CCO_CLD_in_T2D_Downloadable_1.pptxAnshitaAggarwal7
 
Core measures version 3
Core measures version 3Core measures version 3
Core measures version 3mjude2014
 
Formal grand case presentation
Formal grand case presentationFormal grand case presentation
Formal grand case presentationCharry Allana
 
wub ACS.pptx
wub  ACS.pptxwub  ACS.pptx
wub ACS.pptxNatanA7
 
Coronary heart disease - epidemiology
Coronary heart disease - epidemiologyCoronary heart disease - epidemiology
Coronary heart disease - epidemiologyGarima Gupta
 
Painful diabetic peripheral neuropathy diagnosis and management
Painful diabetic peripheral  neuropathy diagnosis and managementPainful diabetic peripheral  neuropathy diagnosis and management
Painful diabetic peripheral neuropathy diagnosis and managementNaveen Kumar
 
Can diabetes make me blind AJAY DUDANI
Can diabetes make me blind AJAY DUDANICan diabetes make me blind AJAY DUDANI
Can diabetes make me blind AJAY DUDANIAjayDudani1
 
Management of Acute Heart Failure
Management of Acute Heart FailureManagement of Acute Heart Failure
Management of Acute Heart Failuredrucsamal
 
Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...
Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...
Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...M. Luisetto Pharm.D.Spec. Pharmacology
 
Differences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomesDifferences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomesdrucsamal
 
Dementia Care at the End of Life
Dementia Care at the End of LifeDementia Care at the End of Life
Dementia Care at the End of LifeVITAS Healthcare
 

Similar to 175972614 cardiomyopathy-mary (20)

Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2Global Facts And Figures 2007 Rev2
Global Facts And Figures 2007 Rev2
 
Part 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPPart 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFP
 
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
1110414-降低糖尿病患者罹患心腎疾病的風險跟血糖達標一樣重要.pdf
 
Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010Diabetes Presentation Nosscr 52010
Diabetes Presentation Nosscr 52010
 
need_for_medical__device_for_older_people
need_for_medical__device_for_older_peopleneed_for_medical__device_for_older_people
need_for_medical__device_for_older_people
 
CCO_CLD_in_T2D_Downloadable_1.pptx
CCO_CLD_in_T2D_Downloadable_1.pptxCCO_CLD_in_T2D_Downloadable_1.pptx
CCO_CLD_in_T2D_Downloadable_1.pptx
 
Core measures version 3
Core measures version 3Core measures version 3
Core measures version 3
 
Formal grand case presentation
Formal grand case presentationFormal grand case presentation
Formal grand case presentation
 
wub ACS.pptx
wub  ACS.pptxwub  ACS.pptx
wub ACS.pptx
 
Pediatric cardiomyopathy
Pediatric cardiomyopathyPediatric cardiomyopathy
Pediatric cardiomyopathy
 
Coronary heart disease - epidemiology
Coronary heart disease - epidemiologyCoronary heart disease - epidemiology
Coronary heart disease - epidemiology
 
Painful diabetic peripheral neuropathy diagnosis and management
Painful diabetic peripheral  neuropathy diagnosis and managementPainful diabetic peripheral  neuropathy diagnosis and management
Painful diabetic peripheral neuropathy diagnosis and management
 
Can diabetes make me blind AJAY DUDANI
Can diabetes make me blind AJAY DUDANICan diabetes make me blind AJAY DUDANI
Can diabetes make me blind AJAY DUDANI
 
Non communicable diseases (final)
Non communicable diseases (final)Non communicable diseases (final)
Non communicable diseases (final)
 
Management of Acute Heart Failure
Management of Acute Heart FailureManagement of Acute Heart Failure
Management of Acute Heart Failure
 
Stroke (1)
Stroke (1)Stroke (1)
Stroke (1)
 
Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...
Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...
Luisetto m, luca c, f. a. khan, g. r. mashori. sudden heart pathology a new r...
 
Differences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomesDifferences in clinical characteristics and its effect for outcomes
Differences in clinical characteristics and its effect for outcomes
 
Ckd 2016 100 1
Ckd 2016 100 1Ckd 2016 100 1
Ckd 2016 100 1
 
Dementia Care at the End of Life
Dementia Care at the End of LifeDementia Care at the End of Life
Dementia Care at the End of Life
 

Recently uploaded

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...anjaliyadav012327
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
 

Recently uploaded (20)

Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 

175972614 cardiomyopathy-mary

  • 1. 1 Get Homework/Assignment Done Homeworkping.com Homework Help https://www.homeworkping.com/ Research Paper help https://www.homeworkping.com/ Online Tutoring https://www.homeworkping.com/ click here for freelancing tutoring sites INTRODUCTION Myocardial (heart muscle) dysfunction occurs very commonly, usually due to other diseases such as coronary artery disease, high blood pressure, and diseases of the heart valves. Disease originating in the heart muscle itself (cardiomyopathy) is much rarer. Unfortunately, by the time it is diagnosed, the disease often has reached an advanced stage andheart failure has occurred. Consequently, about 50 percent of patients with dilated cardiomyopathy live 5 years once heart failure is diagnosed; about 25 percent live 10 years after such a diagnosis. Typically, patients die from a continued decline in heart muscle strength, but some die suddenly of irregular heartbeats.
  • 2. 2 For patients with advanced disease, heart transplantation greatly improves survival: 75 percent of patients live 5 years after a transplantation. However, the disease also may remain fairly stable for years, especially with treatment and regular evaluation by a physician. Cardiomyopathy is a result of pre-existing medical condition and can lead to a more serious heart disease. There are 79, 320 cases of death cause cardiomyopathy in the whole world. The following Table1.1 is showing the mortality rate based from (WHO) World Health Organization Statistics Information Systems compiled January, 2004 . WORLDWIDE MORBILITY CASES OF DILATED CARDIOMYOPATHY The following Table 1.2 attempts to show morbidity extrapolate prevalence rate for Dilated cardiomyopathy to the populations of various countries and regions. These prevalence extrapolations for Dilated cardiomyopathy are only estimates, based on applying the prevalence rates from the US (or a similar country) to the population of other countries, and therefore may have very limited relevance to the actual prevalence of Dilated cardiomyopathy in any region: Country/Region Extrapolated Prevalence Population Estimated Used Dilated cardiomyopathy in North America (Extrapolated Statistics) USA 587,310 293,655,4051 Canada 65,015 32,507,8742 Table 1.1 Mortality Statistics
  • 3. 3 Mexico 209,919 104,959,5942 Dilated cardiomyopathy in Central America (Extrapolated Statistics) Belize 545 272,9452 Guatemala 28,561 14,280,5962 Nicaragua 10,719 5,359,7592 Dilated cardiomyopathy in Caribbean (Extrapolated Statistics) Puerto Rico 7,795 3,897,9602 Dilated cardiomyopathy in South America (Extrapolated Statistics) Brazil 368,202 184,101,1092 Chile 31,647 15,823,9572 Colombia 84,621 42,310,7752 Paraguay 12,382 6,191,3682 Peru 55,088 27,544,3052 Venezuela 50,034 25,017,3872 Dilated cardiomyopathy in Northern Europe (Extrapolated Statistics) Denmark 10,826 5,413,3922 Finland 10,429 5,214,5122 Iceland 587 293,9662 Sweden 17,972 8,986,4002 Dilated cardiomyopathy in Western Europe (Extrapolated Statistics) Britain (United Kingdom) 120,541 60,270,708 for UK2 Belgium 20,696 10,348,2762 France 120,848 60,424,2132 Ireland 7,939 3,969,5582 Luxembourg 925 462,6902 Monaco 64 32,2702 Netherlands (Holland) 32,636 16,318,1992 United Kingdom 120,541 60,270,7082 Wales 5,836 2,918,0002 Dilated cardiomyopathy in Central Europe (Extrapolated Statistics) Austria 16,349 8,174,7622 Czech Republic 2,492 1,0246,1782 Germany 164,849 82,424,6092 Hungary 20,064 10,032,3752 Liechtenstein 66 33,4362 Poland 77,252 38,626,3492 Slovakia 10,847 5,423,5672 Slovenia 4,022 2,011,473 2 Switzerland 14,901 7,450,8672
  • 4. 4 Dilated cardiomyopathy in Eastern Europe (Extrapolated Statistics) Belarus 20,621 10,310,5202 Estonia 2,683 1,341,6642 Latvia 4,612 2,306,3062 Lithuania 7,215 3,607,8992 Russia 287,948 143,974,0592 Ukraine 95,464 47,732,0792 Dilated cardiomyopathy in the Southwestern Europe (Extrapolated Statistics) Azerbaijan 15,736 7,868,3852 Georgia 9,387 4,693,8922 Portugal 21,048 10,524,1452 Spain 80,561 40,280,7802 Dilated cardiomyopathy in Southern Europe (Extrapolated Statistics) Greece 21,295 10,647,5292 Italy 116,114 58,057,4772 Dilated cardiomyopathy in the Southeastern Europe (Extrapolated Statistics) Albania 7,089 3,544,8082 Bosnia and Herzegovina 815 407,6082 Bulgaria 15,035 7,517,9732 Croatia 8,993 4,496,8692 Macedonia 4,080 2,040,0852 Romania 44,711 22,355,5512 Serbia and Montenegro 21,651 10,825,9002 Dilated cardiomyopathy in Northern Asia (Extrapolated Statistics) Mongolia 5,502 2,751,3142 Dilated cardiomyopathy in Central Asia (Extrapolated Statistics) Kazakhstan 30,287 15,143,7042 Tajikistan 14,023 7,011,556 2 Uzbekistan 52,820 26,410,4162 Dilated cardiomyopathy in Eastern Asia (Extrapolated Statistics) China 2,597,695 1,298,847,6242 Hong Kong s.a.r. 13,710 6,855,1252 Japan 254,666 127,333,0022 Macau s.a.r. 890 445,2862 North Korea 45,395 22,697,5532 South Korea 96,467 48,233,7602 Taiwan 45,499 22,749,8382 Dilated cardiomyopathy in Southwestern Asia (Extrapolated Statistics) Turkey 137,787 68,893,9182
  • 5. 5 Dilated cardiomyopathy in Southern Asia (Extrapolated Statistics) Afghanistan 57,027 28,513,6772 Bangladesh 282,680 141,340,4762 Bhutan 4,371 2,185,5692 India 2,130,141 1,065,070,6072 Pakistan 318,392 159,196,3362 Sri Lanka 39,810 19,905,1652 Dilated cardiomyopathy in Southeastern Asia (Extrapolated Statistics) East Timor 2,038 1,019,2522 Indonesia 476,905 238,452,9522 Laos 12,136 6,068,1172 Malaysia 47,044 23,522,4822 Philippines 172,483 86,241,6972 Singapore 8,707 4,353,8932 Thailand 129,731 64,865,5232 Vietnam 165,325 82,662,8002 Dilated cardiomyopathy in the Middle East (Extrapolated Statistics) Gaza strip 2,649 1,324,9912 Iran 135,006 67,503,2052 Iraq 50,749 25,374,6912 Israel 12,398 6,199,0082 Jordan 11,222 5,611,2022 Kuwait 4,515 2,257,5492 Lebanon 7,554 3,777,2182 Saudi Arabia 51,591 25,795,9382 Syria 36,033 18,016,8742 United Arab Emirates 5,047 2,523,9152 West Bank 4,622 2,311,2042 Yemen 40,049 20,024,8672 Dilated cardiomyopathy in Northern Africa (Extrapolated Statistics) Egypt 152,234 76,117,4212 Libya 11,263 5,631,5852 Sudan 78,296 39,148,1622 Dilated cardiomyopathy in Western Africa (Extrapolated Statistics) Congo Brazzaville 5,996 2,998,0402 Ghana 41,514 20,757,0322 Liberia 6,781 3,390,6352 Niger 22,721 11,360,5382 Nigeria 35,500 12,5750,3562
  • 6. 6 Senegal 21,704 10,852,1472 Sierra leone 11,767 5,883,8892 Dilated cardiomyopathy in Central Africa (Extrapolated Statistics) Central African Republic 7,484 3,742,4822 Chad 19,077 9,538,5442 Congo Kinshasa 116,634 58,317,0302 Rwanda 16,477 8,238,6732 Dilated cardiomyopathy in Eastern Africa (Extrapolated Statistics) Ethiopia 142,673 71,336,5712 Kenya 65,964 32,982,1092 Somalia 16,609 8,304,6012 Tanzania 72,141 36,070,7992 Uganda 52,780 26,390,2582 Dilated cardiomyopathy in Southern Africa (Extrapolated Statistics) Angola 21,957 10,978,5522 Botswana 3,278 1,639,2312 South Africa 88,896 44,448,4702 Swaziland 2,338 1,169,2412 Zambia 22,051 11,025,6902 Zimbabwe 7,343 1,2671,8602 Dilated cardiomyopathy in Oceania (Extrapolated Statistics) Australia 39,826 19,913,1442 New Zealand 7,987 3,993,8172 Papua New Guinea 10,840 5,420,2802 Table 1.2 Morbidity Extrapolate Prevalence rate for Dilated Cardiomyopathy Source: US Census Bureau, Population Estimates, 2004 US Census Bureau, International Data Base, 2004 LOCAL MORBIDITY STATISTICS In this Table 1.3 shows the morbidity rate in the Philippines on 2000- 2004 & 2005. The disease of the heart was 7th most leading cause of morbidity cases ranges 43, 898. And highest most leading cause is Acute Lower Respiratory Infection ranging 690,566.
  • 7. 7 Table 1.3 Morbidit:10 Leading Causes, Number and Rate. OBJECTIVES OF THE STUDY General Objectives Readers will be able to gain more knowledge and information about cardiomyopathy. As third year students, we learned patient based heart complication. In this matter, what we learned inside the room will be able to apply to an actual patient depending on the condition his needs. Patient centered - Gather all necessary data of the patient that are related to heart disease that are available as is may be helpful to case study. - Present the definition of the complete diagnosis that will explain the illness or complication. - Study the anatomy and physiology of that certain body part that is affected by the complication. - Trace the pathophysiology of cardiac disease (cardiomyopathy). - Determined the possible diagnostic test needed for the case including implication and nursing responsibility for the needs of the patient.
  • 8. 8 - Formulate a nursing care base plan on the possible secondary complication. - Evaluate complications to nursing practice, education and research. - To render health teachings and guidelines to those patients in the future for them to prevent the risk of heart failure. - The student nurse wants to learn actual complication that may occur on the future. Nurse centered After the completion of the case study the student nurse should be able to: - Present comprehensive and detailed report regarding the complication. - Have a well-structured nursing diagnosis of the complication based on patient integration data. - Understand the factors that might have been contributed to the development of the complication. - To provide an organized and structured nursing interventions as a response to the patient anticipated needs. - Provide relevant information on available alternative therapies and management. NURSING ASSESSMENT FAMILY GENOGRAM Mr. Ferding (code name) not his real name is the youngest siblings from Mr. Swirding(father of client, 65, deceased ) and Mrs. Sorayna(mother of client, 72, deceased). Five of the family membersare alive and well. Three of his brother and two sisters died with a history of cardiac arrest and 2 died in spontaneous abortion. His grandparents on mother side and father side, most of them died in cardiac arrest as he stated when we did an interview with him. See Figure 1.1 to elaborate more on his family tree.
  • 9. 9 Figure 1.1FAMILY TREE (FAMILY HEALTH/ ILLNESS HISTORY) PERSONAL HISTORY Mr. Ferding (code name) not his real name is a 53 yrs. old male born on April 30 1959. His parents are both gone, he has siblings 7 of them are already gone while 6 are still alive. He married his wife (Esme) at the age of 25 yrs. old. Now he is a father of 6 children. Mr. Ferding and his family are protestant. He is a carpenter and is earning enough to support his family including their education. Lifestyle and Activities of Daily Living Family Lifestyle Mr. Ferding works 6 days a week fixing and repairing houses while his wife takes care of their children at home. Their children are quite good and they are cooperative when they are told to do so. Activities of Daily Living Mr. Ferding usually gets up at 5 am to prepare himself to go for work. He will just eat at 6 AM, at 7 AM he will now go to his work. During morning until 12 at noon then have his lunch for 1 hr. After 1 hr. he will now start working again for another 5 hrs. When he comes home at 5 pm he will just take a short break. He will then make sure that all his children is home at 7-8
  • 10. 10 before they eat their dinner. At 9 pm Mr. Ferding usually on bed ready to sleep and prepare for the next day routine. Eating Pattern Mr. Ferding stated that he likes to eat heavy meals because of the kind of his work. He eats fried rice in the morning to sustain his activities. He also eats rice and partner usually with meat or fish and vegetables at noon and dinner. His wife is the one who prepares his food for work. Bowel and Bladder Elimination Mr. Ferding stated that he is usually defecates once a day. Sometimes he exerts effort just to expel it. But when he feels like he is constipated, he drinks warm liquid after a while he will then go to the toilet. He also stated that he have no hard time urinating, there is no pain or any burning sensation. Family Relationship Mr. Ferding stated that he is a family man. He always makes sure that all his children is equally given attention to. He also added that his children are open to share their problems. And as a father he always gives advice with an open minded. Home and Neighborhood Condition Ms. Ferdings house is consisting of 3 bedrooms, 1 for him and his wife, 1 for his girls and the other is for his boys. The bedroom of his children is consisting of bunk beds. They have living room and kitchen. They have friendly neighbors and never had been in the fight before. HISTORY OF PAST AND PRESENT ILLNESS Past Illness According to Mr. Ferding20 years ago he was a smoker then, and was diagnosed with hypertension. He did not comply with maintenance medication because he cannot afford it and he feel like he still have hypertension after a while so he thought he was ok and no need to take it. Present Illness
  • 11. 11 Mr. Ferding decided to go to the hospital because of excessive coughing and feeling of easy fatigability. June 22- 2 weeks prior to admission Mr. Ferding experiences slight chills and fever but he still went to work. When he came home he took Biogesic for his fever and since his daughter is a nurse he just ask her to take his vital signs. Everything was normal but a slightly elevated temperature. The next morning he felt ok. Then decided to go back to work July 6 -1 day prior to admission experienced coughing and feeling of easy fatigability. He did not got to work and he took a rest hoping that it will go away. July 7 - 1 hour prior to admission Mr. Ferdingexperiencedexcessive coughing and DOB. ACTUAL PHYSICAL ASSESSMENT Nutrition assessment The muscle tone of the patient was firm and developed with unequal strength on the upper peripheral extremities. Body fat was equally distributed in the waist thighs and triceps. Posture was erect but difficulty walking. The patient experienced easy fatigability. Skin is rough, dry and decrease skin turgor. Nail was firm and pale nail beds. Hair was brittle and dry. Lips are puffy with visible fissures on the corner of the mouth. Eyes are clear and pale. There was normal reflex. Apical rate of 73 bpm and a blood pressure of 110/70. Skin and nail assessment Brown color skin, there was a thick but smooth texture with a clammy temperature. Skin turgor of 5 seconds. There was a presence of grade 2 edema in the lower extremities. Patient had a black dry hair. Scalp was symmetrical smooth and there was no presence of lesion and no parasites. There was a round nail with 180 O nail base, thick in texture and immobile. Head and Neck Head was symmetrical round hard and smooth. Face was symmetrical centered head position. Neck had a smooth and control movement and ROM of (flexion-45O , extension-55 O ,
  • 12. 12 lateral abduction-40 O , and rotation-70 O .) trachea and thyroid are in the midline position and non-tender. Eyes and Ears Blinking was symmetrical and involuntary. Cornea was transparent, iris and pupils are round and equal. Iris was clear and uniform in color. There was no discharge and tenderness on the lacrimal apparatus upon palpation. Pinna of the ear was aligned with corner of the eye. Skin smooth without nodule and color was the same with the face. Auricle tragus was non-tender upon palpation. Mastoid process was not-tender when palpated, warm in temperature and easily palpated without edema. Mouth throat and nose Lips and surrounding tissues are relatively symmetrical in position. There was fissure and puffiness on the side of the mouth when smiling. Tongue was fissure and moves smoothly and slightly pale in color. Color of the nose was the same as the face, smooth and symmetrical in appearance. There was visible nasal flaring during inspiration. There are no nodules, masses or pain reported during palpation. Sinuses are non-tender during palpation. Chest and Lungs Color in the chest was slightly pallor, intercostals space is retracting during with RR of 24 bpm. Chest symmetrical was equal. There was no pain upon palpation but there was a presence of wheezing sound on both lung fields. Heart Apical pulse was 73 bpm upon auscultation with 53 PR upon palpation. Peripheral vascular Brachial artery blood pressure of 110/70 mmhg, 53 bpm PR. Extremities are slightly pallor. Temperature of 34.2 O can identify pain. Radial pulse was weak and slow. Lower extremities are slightly pallor with grade 2 bipedal edema. Verbalized no calf pain.
  • 13. 13 ANATOMY AND PHYSIOLOGY Figure 1.2 Layers of the heart Pericardial cavity–the space between the layers of the pericardium contains approximately 10 – 30 ml of fluid. Parietal pericardium-surround almost the entire ascending aorta and main pulmonary artery as well as portion of the inferior and superior vena cava and the pulmonary vein. Fibrous pericardium ( Parietal Layer) surrounds the heart and attaches to the great vessels which are several large blood vessels that return blood to the heart. Coronary blood vessel the blood vessels that supplies oxygen and nutrient to the heart itself. Endocardium is the inner layer of the heart where the blood is filled during cardiac relaxation. Myocardium is responsible for contraction and expelling blood during cardiac contraction. Epicardium( Visceral Pericardium ) contains the epicardial coronary arteries and veins. This is the inner lining of the pericardium; it is delicate inner lining of the parietal pericardium and is the outer lining the great vessel. (See figure 1.2)
  • 14. 14 Figure1.3Bloodflowillustration Blood Flow First, superior vena cava carries deoxygenated blood from the upper extremities while inferior vena cava carries .deoxygenated blood from lower extremities. From the vena cava’s blood will drain in the right atrium. From the right atrium blood will now go to the right ventricle through the tricuspid valve. From right ventricle deoxygenated blood will pass through the pulmonary valve and pulmonary artery going to the pulmonary trunk and lungs for the process of oxygenation. In the lungs blood will release carbon dioxide and will be oxygenized. Blood will pass through the pulmonary vein down to the left atria. From left atria the mitral valve will open and will be drain down to the left ventricle. The left ventricle now will pump the oxygenated blood towards the aortic valve ascending and descending aorta. The oxygenated blood is now going to for the systemic circulation. The movement of the blood through the heart is controlled by the opening and closing of the valves and the contraction and relaxation of the myocardium. Coronary circulation delivers oxygenated blood to myocardium and removes carbon dioxide from it. Deoxygenated blood
  • 15. 15 from the heat returns to the atria via coronary sinus. (See Figure 1.3)Malfunction of this system can result to angina pectoris or myocardial infarction. Figure 1.4 SA node and AV node Conduction system of the heart The conduction system of the heart consists of specialized cardiac muscle tissue that generates and distributes action potential. Components of this system are the sinoatrial (SA) node this is the peacemaker, and initiate the cardiac contraction by passing electric impulse to atrioventricular (AV) node(See Figure 1.4),in which this node passes the electric impulse going to the bundle of his. From the bundle of His electric impulse will pass through the purkenji fibers. Thus, cardiac contraction happens.
  • 16. 16 PATHOPHYSIOLOGY(Patient based) Figure 1.5 Pathophysiology (Patient-Based)
  • 18. 18 DEFINITION OF THE DISEASE Heart muscle disease is called cardiomyopathy and is a problem with the physical shape of the muscle. Often its origin is unknown. Cardiomyopathy is a serious condition that can lead to heart failure, dysrhythmias and death. SYNTHESIS OF THE DISEASE RISK FACTORS (patient based)  Genetic factor-if the person has a family history of heart diseases 20-30% possibility that he/she will acquire that disease from them as it already runs on the genes. (Daniels 2010). From the start a person with family history of cardiomyopathy has already a cardiac abnormalities and its unknown if this will progress to full cardiomyopathy to later life. There is a presence of disease genes (dystrophin, tatazzin, cardiac actin, desmin, Lamin A/C, delta-sarcoglycan, cardiac beta myocin heavy chain, and cardiac troponin T-gene). The mutation in Lamin A/C is the one that causes cardiomyopathy. Other mutations are the cause in addition skeletal muscle myopathy. Dystrophinmutation are the cause of the rare X-linked dilated cardiomyopathy without skeletal muscle involvement and a progressive course in young men. Other mutation in dystrophin gene, mainly deletion , are the cause of muscular dystrophy Becker and Duchenne which are also present in dilated cardiomyopathy.  Age-the higher the age of a person the higher the risk for heart diseases because of the degeneration of the tissues. And the presence of atherosclerotic disease that usually occurs in the late stage of life. This atherosclerosis causes a strain in the heart muscle because of compensatory mechanism of the body usually being a tachycardic.  Gender- male is more prone to having cardiac related diseases than the female because of the vices (smoking, drinking). This activity causes the destruction and toxicity of cells in the heart. PRECIPITATING FACTOR  Smoking- cigarrete containa chemical nicotine that is responsible in the hardening of the arteries that causes increase workload in the heart that may lead to myocardial disease or heart failure. While the carbon monoxide toxicity causes the heart to weakens.
  • 19. 19  Respiratory infection- bacterial infection causes increase in secretion causing coughing and increase in oxygen demand leading to a compensatory mechanism of the body such as increase in heart rate and respiratory rate.  easy fatigability s being experienced because of the increase in oxygen demand  cough because of the reaction of bacterial infection in the RR system  Pulse deficit most possible is because of the medication specifically the Digoxin. SIGNS AND SYMPTOMS (patient based) Signs and symptoms Rationale Fever The high temperature of the patient is caused by respiratory infection by the inflammation of the tracheal and bronchial area, due to pathogenic invasion. The inflammation will cause releasing of pyrogens from cells. These endogenous pyrogens will stimulate the release of prostaglandin that will trigger the hypothalamic thermostat to higher temperature. Hypertension Or high blood pressure. It is because of decrease vascular regulation(atherosclerosis) resulting from malfunction of arterial blood flow due to formation of clots. And then there would be elevated blood pressure that will lead to increased heart rate. Easy fatigability Due to continuous exertion of heart and increase in oxygen demand. It will cause an overuse stage and eventually the body will experience of feeling weakness, tiredness and listlessness. Impaired gas exchange Due to myocardial dysfunction secondary to decrease mayocardial contraction there would be an abnormal perfusion. That explains the amount of blood ejected from left ventricle diminished and the heart cannot pump enough blood to meet body needs. It will cause limited airflow which leads to decreased cardiac output. Activity intolerance Due to long term HPN and irregular cardiac pattern there is an impaired heart muscle resulting to decrease its capacity to function normally also resulting to decrease blood volume and oxygen in the systemic circulation causing easy fatigability
  • 20. 20 Nail and skin color changes Decrease cardiac output and decrease arterial perfusion will cause abnormal process of circulation to a capillary bed in blood tissue that affects the skin color changes and the extremities. Abnormal urine output -Decrease cardiac output and decrease RBC will cause R-A-A stimulation. It means that there is re-absorption of sodium and water in the blood. It will bring about by fluids and electrolytes imbalances. -Due to decrease kidney function there is an improper absorption of water and wastes from the blood stream. Edema Due to decrease kidney function and R-A-A stimulation the retention of too much salt causes the body to retain water. This water then leaks into the interstitial tissue space. This is what we call edema. TREATMENT DIAGNOSTICS AND LABORATORY PROCEDURES General nursing responsibilities  Check doctors order  Explain to the client the importance of the test and what it is for ECG Before  Remove all metals attached to the body  Make sure your health care provider knows about all the medications you are taking, as some can interfere with test results.  Exercising or drinking cold water immediately before an ECG may cause false results.  An ECG is painless. No electricity is sent through the body. The electrodes may feel cold when first applied. In rare cases, some people may develop a rash or irritation where the patches were placed.
  • 21. 21 During  You will be asked to lie down. The health care provider will clean several areas on your arms, legs, and chest, and then attach small patches called electrodes to the areas. It may be necessary to shave or clip some hair so the patches stick to the skin. The number of patches used may vary.  The patches are connected by wires to a machine that turns the heart's electrical signals into wavy lines, which are often printed on paper. The test results are reviewed by the doctor.  You usually need to remain still during the procedure. The health care provider may also ask you to hold your breath for a few seconds as the test is being done. Any movement, including muscle tremors such as shivering, can alter the results. So it is important to be relaxed and relatively warm during an ECG recording.  Sometimes this test is done while you are exercising or under minimal stress to monitor changes in the heart. This type of ECG is often called a stress test. After  Remove the patches slowly Diagnostic/laboratory procedure Date ordered: July 7, 2012 General description Indication or purpose Result Normal values Analysis and interpretation ECG Date result in: July 7, 2012 Standardized recording of electrical activity of the heart To detect cardiac ischemia and abnormal rhythms. PR-0.30 seconds QRS-0.06 seconds QT-0.26 seconds PR-0.12- 0.20 sec QRS-0.06- 0.12 sec QT-0.32- 0.44 sec The PR wave wasprolong. The QRS is normal. The QT is shorter than normal. URINE TEST Before  Instruct the patient to void directly into a clean, dry container. Sterile, disposable containers are recommended.
  • 22. 22 During  Cover all specimens tightly, label properly and send immediately to the laboratory.  If a urine sample is obtained from an indwelling catheter, it may be necessary to clamp the catheter for about 15-30 minutes before obtaining the sample. Clean the specimen port with antiseptic before aspirating the urine sample with a needle and a syringe. After  Observe standard precautions when handling urine specimens.  If the specimen cannot be delivered to the laboratory or tested within an hour, it should be refrigerated or have an appropriate preservative added Diagnostic/labo ratory procedure Date ordered: July 7 2012 General description Indicatio n or purpose Result Normal values Analysis and interpretatio n URINE TEST Date result in: July 7 2012 Urine test is a test where in urine is being collected to examine in a microscope To determine the proper function of the kidney Color-yellow Transparency- clear PH-4.0 Specific gravity-1.020 Albumin-trace Sugar-negative Pus cels-HPF- 2.4 RBC/HPF-2.4 Epithelial cells-few A.urates- few Color- yellow Transparency- clear PH-4.6-8 Specific gravity- 1.003-1.025 Albumin- Sugar-Nil Pus cells- RBC-1- 02/low power field 1/ high power field Epithelial cells, and A urates can be found in the urates in a few number Color is normal Transparency normal PH- is in normal range Specific gravity-is in normal range No sugar found indicating its normal RBC is slightly above the normal range And it is normal for the epithelial and A urates to be found in the urine providing in a few number. BLOOD TEST Before  Nurses must help position patients properly, like rolling the patient over, in order to complete the necessary diagnostic testing.
  • 23. 23  Check a patient's vital signs (blood pressure, pulse, breathing rate), assess physical condition and keep an eye on any monitors that the patient needs to remain hooked up to during the tests, such as a heart monitor or ventilator. Nurses may also be required to connect or disconnect any monitors or devices that can interfere with the testing. During  Draw the sample before giving or one hour after giving I.M. injections. I.M. injections will increase the total CK level.  Be sure to obtain the blood samples on schedule. Always note on the laboratory slip, the time the sample was drawn and the hours elapsed since onset of chest pain. Be sure to draw blood samples in a 7-ml red top tube.  Be sure to handle the sample gently to prevent hemolysis. Always have the sample transported to the lab promptly because CK activity diminishes significantly after 2 hours at room temperature. After the procedure  Apply cotton ball with slight pressure to the site to bleeding.  Test results are reported to the patient's doctor, specialists and others in need of the information by nurses. Results may be phoned in, faxed or sent electronically via a computer. It may be the nurse's responsibility to check for the results of the tests as well. They may be in charge of entering the results into the patient's medical record. Nurses must also notify the patient's physician when abnormal or critical results that require an immediate response, such as abnormal blood work with critical potassium levels, are found. Diagnostic/labo ratory procedure Date ordered: July 7 ,2012 General descriptio n Indicatio n or purpose Result Normal values Analysis and interpretatio n Blood test Date result in: July 7, 2012 Blood chemistry Give specific informatio n about the condition of your organs. RBS-6.88 BUN-4.0 Createnine- 98.3 CK-MB-8.18 Troponin I-Nil RBS-3.85- 9.0mmol/l BUN-1.7- 8.3mmol/l Createnine- 60- 120mmol/l CK-MB-0- RBS is in normal range BUN is in normal range CREATENIN E is in normal range CK-MB is
  • 24. 24 Sodium-141.9 Potassium- 3.45 Hemoglobin- 144 Hematocrit-43 WBC-11.4 Neutrophils-.7 Platelet count- 248 25IV/l Troponin- Nil Sodium- 135- 145mmol/l Potassium- 3.5- 5.5mmol/l Hemoglobi n-125- 175mmol/l Hematocrit- 0.40-0.52 WBC-5- 10x10/l Neutrophils -0.45-0.65 Platelet count-150- 400x10?l isnormal range There is no troponin I found SODIUM is in normal range POTASSIU M is slightly low HEMOGLOB IN is in normal range HEMATOCR IT is in normal range WBC is slightly elevated NEUTROPHI LS is in normal range PLATELET COUNT is in normal range Diagnostic/labo ratory procedure Date ordered: July 7, 2012 General descriptio n Indicatio n or purpose Result Normal values Analysis and interpretatio n Blood test Date result in: July 7 2012 HEMATOL OGY To determine the total volume of blood HGB-143 WBC-8.8 RBC-5.0 HCT-0.43 HGB-140- 180gm/l WBC-5- 10x10mo/l RBC-4.5- 6.3x10/l HCT-0.40- 0.54L/L HGB is in normal range WBC is in normal range RBC is in nor mal range HCT is in normal range
  • 25. 25 Diagnostic/labo ratory procedure Date ordered: Date result in: General descriptio n Indicatio n or purpose Result Normal values Analysis and interpretatio n Blood test July 7 2012 Chemical chemistry To determine the proper function of the heart BUN-2.8 CREATENIN E-70.8 SODIUM- 143.8 POTASSIUM- 3.55 BUN-2.1- 7.1mmo1/l CREATENI NE-62- 106mmol/l SODIUM- 135- 148mmol/l POTASSIU M-3.5- 5.3mmol/l BUN, CREATENIN E, SODIUM, POTASSIUM are all in normal range IVF Before  Lean the site with cotton balls with alcohol During  Make sure to maintain bed rest  Continues cardiac monitoring  Report any abnormal findings to the physicians  Increase the rate of infusion as prescribe, but monitor for fluid overload  No evidence of dehydration should be noticed  Check the IV site for redness, swelling and infiltration After  Apply cotton balls to the site to prevent bleeding MEDICAL MANAGEMENT Date ordered: July 7 Date started: July 7 Date Changed: July 8 GENERAL DISCRIPTION INDICATION PORPOSE CLIENT’S RESPONSE 1ST D5LRS 1LxKVO D5LRS are fluids which are intended to be administered because hypertonic solution are those that have an effective osmolarity greater than the body fluids. This pulls thefluids into thevascular by osmosis resulting in an increase vascular volume .It raises intravascular osmotic pressureand provides fluid, electrolyteand calories for energy. Client maintain fluid balance despiteof strict monitoring of I&O
  • 26. 26 O2 THERAPHY Before  Instruct the client and visitors about the hazard of smoking with oxygen use.  Make sure that electric devices (such as razors, hearing aids, radios, televisions, and hearing pads) are in good working order to prevent the occurrence of short-circuit sparks. Ensure proper delivery method (cannula, face mask, face tent)  Teach client proper use of oxygen During  Avoids materials that generate static electricity, such as woolen blankets and synthetic fabrics. Cotton blankets should be used, and client and caregivers should be advised to wear cotton fabrics.  Regulate flow if necessary After  Always make sure that the oxygen tank is properly closed MEDICAL MANAGEMENT Date ordered July 7, 2012 Date started July 7, 2012 GENERAL DESCRIPTION INDICATION PORPOSE CLIENT’S RESPONSE OXYGEN 1-2 liter/min Oxygen is a colorless gas that exists in the air that all living things needed in order to live. To provide enough oxygen despite of difficulty of breathing Patient was relieved experiencing DOB DRUGS General nursing responsibilities Before  Check doctor’s order  Explain to the patient what the medication is for. During: During  Give the medication on time. After:
  • 27. 27  Document the medication done. CEFTRIAXONE Before  Read carefully the name cephalosporin’s have similar sounding and similar spelled names.  Reconstitute 1 mL of cephalosporin to 5 mL of sterile water. Determine allergy to the cephalosporin through skin testing. During  Do no infuse rapidly, it causes pain and irritation Name of the drug: Date ordered: July 7, 2012 Route: IV infusion General action Indication Clients response to the actual adverse reaction Date started: July 7, 2012 3rd generation cephalosporin antibiotic Lower respiratory infection due to pneumonia The client did not manifest any S&S of infection Generic name: Ceftriaxone sodium Dosage and frequency: 1 gm Q12 Brand name: Rocephin Date discontinued: July 9, 2012 FUROSEMIDE Before  Do not confuse Lasix with Lanoxin (a cardiac glycoside)  Asses closely for a sign of vascular thrombosis and embolism.  Take Blood Pressure before administering the medication give IV injection slowly, may cause pain and irritation. During  Do not infuse rapidly After  For rapid diuresis observe for dehydration.  Assess for S and Sx for hyperkalemia.  Let the client change the position from lying to sitting the stand slowly.  Supplement diet with vegetable and fruits that are high in potassium. (ex. Bananas, peaches and oranges.)
  • 28. 28 Name of the drug: Date ordered: July 7, 2012 Route: IV bolus General action Indication Clients response to the actual adverse reaction Date started: July 7, 2012 Loop Diuretic Edema There was in increase in urine output from 45cc in 2 hrs. to 300cc in 5 hrs.Generic Name: Furosemide Dosage and frequency: 40 mg Q 6° (12 , 6) Brand Name: Lasix Date discontinued: July 8 2012 AMIODARONE HYDROCHLORIDE Before  Correct potassium and Magnesium During  Follow recommended dietary guidelines. Avoid or limit salt and fluid as directed. Avoid grape fruit. After  Record BP and pulse for providers review. Identify specific levels to hold drugs. HR <60, BP <90/60. Name of the drug: Date ordered: July 7 Route: Oral General action Indication Clients response to the actual adverse reaction Date started: July 7 Antiarrhytmic Prolong the duration of the membrane action potential(relative refractory period) without the change the phase of depolarization or the resting action membrane potential. The client maintains a normal heart rate of 73 bpm Generic Name: Amiodarone Hydrochloride Date discontinued: July 9, 2012 Dosage and frequency: O.D. ( 8 ) Brand Name: Cordarone, Pacerone
  • 29. 29 LOSARTAN POTASSIUM Before  Do not confuse Lozaar with Zocor (Antihyperlipidimic) .  Take pulse rate and BP before administering medication. After  Low fat, low sodium diet and avoid grape fruit.  Do not change position suddenly. Name of the drug: Date ordered: July 7, 2012 Route: Oral General action Indication Clients response to the actual adverse reaction Date started: July 7, 2012 Date discontinued: July 9, 2012 Antihypertensive, Angiotensin II receptor blocker Antihypertensive, alone or with combination with other antihypertensive drugs(including diuretics). Reduces risk of stroke in clients with hypertension and left ventricular hypertrophy. The patient maintains a normal blood pressure of 110/70 mmhg Generic Name: Losartan Potassium Dosage and frequency: 50 mg (8 )Brand Name: Lozaar LEVOFLOXACIN Before:  Check if patient is able to swallow or in need of NGT.  Prepare the medication and other materials to be used. Name of the drug: Date ordered: July 7, 2012 Route: Oral General action Indication Clients response to the actual adverse reaction Date started: July 7, 2012 Date discontinued: July 9, 2012 Flouroquinolone Antibiotic 5 day treatment regimen for community acquired pneumonia due to Streptococcus The patient prevent further infectionGeneric Name: Levofloxacin Dosage and frequency: Oral (8 )Brand Name: Levaguin,
  • 30. 30 Quixin Pneumoniae. DIGOXIN Before  Monitor bradycardia/ arrhythmias, count apical rate for atleast one minute. Before administering.  Have digoxin immune FAB available After  Monitor for pulse deficit. (It indicates adverse drug reaction.)  For severe toxicity.  Use caution: Digoxin withdrawal may worsen heart failure.  Take at the same time each day.  Do not change brands. Name of the drug: Date ordered: July 7, 2012 Route: Oral General action Indication Clients response to the actual adverse reaction Date started: July 7, 2012 Date discontinued: July 9, 2012 Cardiac Glycoside Propylaxis and treatment of recurrent paroxysmal AV junction rhythm. The patient maintains a normal heart rate of 73 bpm Generic Name: Digoxin Dosage and frequency: 25 mg ( 8 ) Brand Name: Lanoxin POTASSIUM CHLORIDE Before  Obtain renal function test, dysfunction leads to hyperkalemia.  Prepare the medication. During  Do not draw or dissolve in the mouth.  Monitor I/O. After
  • 31. 31  Report any sign of weakness, fatigue or cardiac arrhythmias, it is a sign of hypokalemia.  Record the medication done.  Monitor input/output Name of the drug: Date ordered: July 7. 2012 Route: Oral General action Indication Clients response to the actual adverse reaction Date started: July 7, 2012 Date discontinued: July 9, 2012 Electrolytes Hypokalemia with or without metabolic acidosis following in increase urinary excretion. The client maintains a normal level of K of 3.55Generic Name: Potassium Chloride Dosage and frequency: O.D. (8 )Brand Name: KaliumDurule CALCIUM GLUCONATE Before  Do not administer together with other medication  Make sure provider is aware of all the medication prescribed. Name of the drug: Date ordered: July 7,2012 Route: IV General action Indication Clients response to the actual adverse reaction Date started: July7, 2012 Date discontinued: July 8, 2012 Calcium salt Prophylaxis of hypocalcemia during exchange transfusion The client maintains a normal level calcium in the bloodGeneric Name: Cagluconate Dosage and frequency: 1 ampule STATBrand Name: Cal-G MAGNESIUM SULFATE Before  Asses for absent patellar reflex, <100ml in for hr urine output  Asses for Sign and symptoms of hypermagnesemia (flushing, sweating, hypotension or hypothermia) Name of the Date Route: General Indication Clients response to the
  • 32. 32 drug: ordered: July 7,2012 IV action actual adverse reaction Date started: July 7, 2012 Date discontinue: July 7, 2012 Miscellaneous, essential element for muscle contraction, certain enzyme, and nerve transmission Replacement therapy in Mg deficiency especially in acute hypomagnesaemia accompanied by signs of tetany similar to those seen in hypocalcemia The client maintains normal HRGeneric Name: Magnesium sulfate Dosage and frequency: 2 gram STAT Brand Name: Epsom salt ASPIRIN Before  Have epinephrine available to counter act hypersensitivity occurs  Note history of peptic ulcer or bleeding tendencies During  Take with full glass of water to prevent lodging in esophagus After  Inform the patient to report ringing in the ear, difficulty hearing, dizziness or fainting spells, unusual increase in sweating, severe abdominal pain or mental confusion (this is a sign of a toxic effect) Name of the drug: Date ordered: July 7,2012 Route: Oral General action Indication Clients response to the actual adverse reaction Date started: July 7, 2012 Date discontinued: July 7, 2012 Inhibit platelet aggregation Use for cardiovascular disease Patient prevents platelet aggregation Generic Name: Acetylsalicylic Acid Dosage and frequency: 80 mg OD Brand Name: Aspirin DIET Before
  • 33. 33  Check the doctor’s order. Question for any inconsistencies regarding patient’s diet and condition  Explain the importance of diet prescribed After  Document intake as to amount and provide a separate sheet for fluid and output  Take note of patient’s response to the diet ACTIVITY BED REST Before  Explain to the patient why it is necessary  Inform the patient to wear pressure stocking and explain why it is necessary During  Always make sure that there is somebody with him to assist his needs  Make sure your patient is changing position at least every two hours as permitted by her doctor to avoid bed sores that will put her into risk of impaired skin integrity related to immobility.  Always elevate the bedrails After  Let the client stand or move in a gradual motion MEDICAL MANAGEMENT Date ordered: July 7, 2012 GENERAL DISCRIPTION INDICATION PURPOSE CLIENT’S RESPONSE TYPE OF DIET GENERAL DESCRIPTION INDICATION/PURPOSE SPECIFIC FOOD TAKEN LFLS Low fat and low sodium diet To prevent the further accumulation of atherosclerotic plaque that will contribute to increase workload of the heart. pineapple Soft diet Fluid or soft food To prevent constipation that may stimulate the vagus nerve and lead to heart failure. Water, arozcaldo
  • 34. 34 Bed Rest Date started: STAT A medical treatment involving a period of consistent (day and night) recumbence in bed and Reducing activities. Prevent any restraints that can cause easy fatigability and further problem to the heart The patient was cooperative and reduces the feeling of easy fatigability. DAILY PATIENT’S RECORD/EVALUATION Days Admission-Day 1(July 7, 2012) Day 2(July 8, 2012) Nursing problems Cough, easy fatigability Easy fatigability Vital signs BP-110/70, RR-17, PR-78, Temp-36° BP-110/70, RR-24, PR-53, Apical-78, Temp-36.2 laboratory Hematology, chemical chemistry, urinalysis, blood chemistry, electrolytes None IVF, O2 D5LRS 10 gtts (KVO) O2-2 LPM #2 D5LRS D5LRS 10 gtts (KVO) O2-2 LPM Drugs Ceftriaxone 1 gm q12°, furosemide 40 mg IV q6°, MgSO4 2 gm IV STAT, Cagluconate 1 amp IV STAT, amiodarone 200 mg OD, Losartan 50 mg 1 tab OD, Lanoxin 25 mg 1/2 tab OD, levofloxacin 500 mg 1 tab OD, kaliumdurule 1 tab BID, aspirin 80 mg 1 tab OD Levofloxacin500 mg 1 tab OD, , lanoxin25 mg 1/2 tab OD, kaliumdurule, furosemide 40 mg IV q6°, ceftriaxone1 gm q12°,, losartan50 mg 1 tab OD, Kalium durule1 tab BID , amniodarone 200 mg OD Diet NPO LFLS Activity Bed rest Bed rest
  • 35. 35 DISCHARGE PLANNING Strategy Objective Content Time frame Resources Deep breathing exercises To improve the lung capacity thus decreases the workload of the heart DeepBreathing Exercises Deep breathing is a relaxation technique that can be self-taught. Deep breathing releases tension from the body and clear the mind, improving both physical and mental wellness. We tend to breathe shallowly or even hold our hold our breath when we are feeling anxious. Sometimes we are not even aware of it. Shallow breathing limits your oxygen intake and adds further stress to your body, creating a vicious cycle. Breathing exercises can break this cycle How to do DeepBreathing Exercises: 1.Sit up straight. (Do not arch your back) First exhale completely through your mouth. 2.Place your hands on your stomach, just above your waist. 2.Breathe in slowly through your nose, pushing your hands out with your stomach. This ensures that you are breathing deeply. 3.Imagine that you are Every time necessary Teaching and demonstration
  • 36. 36 filling your body with air from the bottom up. 4.Hold your breath to a count of two to five, or whatever you can handle. It is easier to hold your breath if you continue to hold out your stomach. 5.Slowly and steadily breathe out through your mouth, feeling your hands move back in as you slowly contract your stomach, until most of the air is out. Exhalation is a little longer than inhalation. 6.After you get some experience you don’t need to use your hands to check your breathing. You can also do the above breathing exercise lying on your back. Deep breathing exercises can help you to relax before you go to sleep for the night, or fall back asleep if you awaken in the middle of the night. You can also practice deep breathing exercises standing – e.g. while sitting in traffic, or standing in a lineup at the grocery store. If you are really tense and feel as if you are holding your breath, simply concentrate on slowly breathing in and out.
  • 37. 37 Strategy Objective Content Time frame Resources Early Ambulation To improve cardiac muscles and improve its function Safety tips for Stair Climbing Safety and effective climbing should be your goal for stair climbing. The following safety tips can help you start an effective stair climbing regime:  Keep people informed about stair climbing whether at office or home.  Always carry water or fluids with you.  Be aware of your knee alignment as it can cause a knee or ankle sprain.  Inspect the stairs before climbing them as an exercise.  Watch out for opening doors at the end of the stairway. What is the Ideal Way to Start Stair Climbing? Any aerobic exercise should be started very slowly and gradually. The ideal form of any exercise or stair climbing should take care of the following:  1. 5-15 minutes of warm up exercises are absolutely Once a day Health teaching
  • 38. 38 essential for starting anyworkout session   2. Start climbing with gradual slow steps.   3. You can alternate between quicker and low step routines andslower and deep step routines.  4. Finally, relax and cool yourself down.  Control the intensity of your exercise and do not over-exert yourself in your first and initial attempt. Set a goal for yourself like increasing the pace by one flight of stair per week Strategy Objective Content Time frame Resources Low fat Low sodium Diet To avoid the formation of atherosclerotic plaque By following such diet, the risk of heart disease, gallbladder disease, diabetes, and even some forms of cancer is greatly reduced. It is also a great way to lose weight. Throughout the day Health teachings
  • 39. 39 Example of a low fat low sodium diet Breakfast-scramble egg, diced mushroom and red and green peppers, oatmeal with a sliced banana Lunch- fresh fruits and vegetables salad with baked fish or chicken on top Dinner- boiled fresh vegetables All you need is 30 minutes of moderate-level physical activity on most days of the week. Examples of such activities are brisk walking, bicycling, raking leaves, and gardening. Strategy Objective Content Time frame Resources Moderate active ROM exercise To prevent sudden onset of rapid heartbeat .Range-of- motion exercise enhance muscle flexibility. All you need is 20-30 minutes of moderate-level physical activity on most days of the week. Examples of such activities are 1.Chin to chest 2. Head turns 3. Head tilts 4. Shoulder movement, up and 30 minutes everyday Health teachings
  • 40. 40 down 5. Shoulder rotation 6. Elbow bends up and down 7. Elbow bends side to side 8. Wrist rotation 9. Palm up, palm down 10. Finger bends 11. Finger spread 12. Hip and knee bend 13. Leg movement side to side 14. Leg rotation 15. Knee rotation 16. Ankle and toe bends 17. Ankle and toe rotation
  • 44. 44 ACTIVITY INTOLERANCE SUMMARY Some people who have cardiomyopathy have no signs or symptoms and need no treatment. For other people, the disease develops quickly, symptoms are severe, and serious complications occur. Treatments for cardiomyopathy include lifestyle changes, medicines, surgery, implanted devices to correct arrhythmias, and a nonsurgical procedure. These treatments can control symptoms, reduce complications, and stop the disease from getting worse Cardiomyopathy is a common disease affecting more than 1 million people around the world. There are so many contributing factors that trigger the onset of this cardiac disease. Based on our patient some of these factors are (age, family history, gender, and history of smoking). It is hard to predict if the person is when he/she is going to acquire the disease. Easy fatigability
  • 45. 45 and cough was the symptom why the patient admits himself in the hospital for he perceives that it was a life threatening situation for her. Diagnostics was required to determine the exact problem and the treatment is consists of combination of medication in order for his heart to function on is normal. But this is not enough there should be a strict and continuous monitoring of the patient status in order for the patient to recover faster. RECOMMENDATION Patient with or without a family history of cardiac disease (cardiomyopathy) should be very cautious in terms of life style and should avoid the triggering factors that will cause this disease to emerge. All people is risk to having different kind of diseases how much more of those who have a history. Therefore we recommend that everyone should be concern and be knowledgeable about things that are needed to do. As a student nurses it is our responsibility to enforce teachings that will maintain or at least prevent the occurrence of problem and thus it will help create a healthy community. LEARNING DERIVED Policarpio, Jeffrey S. ICU is the second rotation I had since starting my clinical duty. Compared to delivery room, ICU is more in depth when it comes to giving patient care. Due to the time spent with patient, I was able to develop other nursing care skills. I was able to practice my skills with compassion due to prolonged time spent with patient. Nursing is not just giving treatment; it is how you give care. As early as now, I am learning to incorporate compassion with my chosen profession. Familiarizing myself with patient’s chart, drug administration and utilizing different hospital machines such as mechanical ventilator, ECG and atrial defibrillator, provided me with understanding of nursing practice in a whole new level. With this rotation, I had gained more awareness with the practice of infection control not just for me but especially for the patient. Patients in ICU had to deal not just with their major diagnosis but also complications. In line with this, practicing good handwashing, masking and maintaining cleanliness, is my way of showing I care. In my mind, if I don’t practice infection control, this will expose my patients to more medical problems mainly that their immune system is already compromised. Delivery room is a fast paced environment. In ICU, it gives me more time to know not just my patients’ medical problems but my patient as a person as well. My patients need me and depend on me with their needs, thus, I need to show that they can count on me just to relieve them a little bit of what they are going through. Moreover, in ICU, I need to give individualized care which gave me the opportunity to learn more about different nursing interventions. Critical thinking is always a part of nursing practice. My ICU experience gave me the opportunity to practice this skill, taking into consideration the welfare of my patient, thus showing that nurses are not just mechanical workers that move in a routine manner. Nevertheless, nurses move with precise interventions and with compassion.
  • 46. 46 It will always be in my mind that in my chosen career, I deal with human beings. These human beings, sometimes needs machines to survive in ICU, but it will make a big difference if a nurse incorporates love when using those machines with them. And for sure, the patient will know the difference of a nurse who provides interventions just for the heck of it and a nurse who moves with passion and care. ROWENA P. LIGON Being in the ICU is a challenging experience a student nurse will acquire. Having an actual patient is very crucial part in the studies of a student nurse. This is the time of realization that life of a person is at risk if the person that will handle that patient is not equipped with knowledge on how to handle a patient. Knowing the Patient that as a student nurse will provide an assessment in the ICU is a very important step. The student nurse should know to protect the privacy and the integrity of the patient assigned to him/her. The student nurse will not only base his/her analysis from the questions and assessment being conduct to his assigned patient, but rather to gather all the necessary data from other sources like the laboratory results, genogram that will support to have accurate case study. IRISH SANTOS Data collection, assessment taken, is where everything must start, because if a student nurse fail to determine the needs of the patient, there will be a failure to the speedy recovery of his Patient. Communicating skills is also a very crucial stage of assessment for a student nurse to be able to gain their trust you must establish rapport. Health teaching is very necessary due to lack of knowledge to some patient. Teaching them the importance of seeking immediate help when they feel that something is wrong to them, in order to treat the problem immediately. We have to be cautious enough about our health to live longer and be with our love ones. Like the famous saying: “Health is wealth”.Being free from disease is to live a healthy lifestyle. It is up to the person how they will utilize the resources around them.
  • 47. 47 MARY LEZ D. PERRY Though it was my first time to be assign in the ICU I learned so many things that a student nurse should know. Some of it was very unfamiliar to me, like the negatoscope, the solucet, and it was my first time to observed somebody doing a sunctioning. I was able to understand how ECG is being apply to the chest. I was I able to understand what the lines mean in the ECG result. It was my first time to administer lantus to a patient. It was a very nice experience taking care of the patient. I was able to observe what could be a patient would ned in the situation where in nobody want to be. MARK OLIE B. LAYAG Being in ICU, the first thing that comes in my mind are those patients who are in critical condition. Having an actual patient is very crucial part in the studies of a student nurse. . I felt very nervous because I don’t know what I will expect in ICU and what are the things should be done. You are going to analyze an ethical conflict and come up with a course of action that is morally defensible and medically reasonable. And assist patients and their families at time of critical illness with respect, concern for their dignity, and careful attention to pain control and suffering. The most I learned is to how to prioritize the needs of the patients. On how to be attentive on monitoring because we know that these patients need to be closely monitored because of their situation.
  • 48. 48 REFERENCES MEDICAL SURGICAL (CONCEPTS AND CLINICAL APPLICATION) 2ND EDITION 2009 JOSIE QUIAMBAO UDAN NURSE’S POCKET GUIDE (DIAGNOSES INTERVENTIONS AND RATIONALES MARILYN E. DOENGES, MARY FRANCES MOORHOUSE, ALICE C. MURR POCKET NURSES’ DICTIONARYBY GUPTA CONTEMPORARY MEDICAL-SURGICAL NURSING VOLUME 1 RICK DANIELS, LAURA NOSEK, LESLIE NICOLL DELMAR’S NURSE’S DRUG HANDBOOK 2010 EDITION GEORGE r. SPRATTO, ADRIANNE l. WOODS NURSE’S HANDBOOK OF HEALTH ASSESSMENT SIXTH EDITION WILLIAM &LIPPINCOT INTRODUCTION TO THE HUMAN ANATOMY 7TH EDITION TORTORA & DERRICKSON